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ABSTRACT
The Visceral Leishmaniasis (VL) is primarily endemic in five countries, with India
and Sudan having the highest burden. The risk factors associated with VL are either
unknown in some regions or vary drastically among empirical studies. Here, a dy-
namical model, motivated and informed by field data from the literature, is analyzed
and employed to identify and quantify the impact of region dependent risks on the
VL transmission dynamics. Parameter estimation procedures were developed using
model-derived quantities and empirical data from multiple resources. The dynamics
of VL depend on the estimates of the control reproductive number, RC , interpreted
as the average number of secondary infections generated by a single infectious indi-
vidual during the infectious period. The distribution of RC was estimated for both
India (with mean 2.1± 1.1) and Sudan (with mean 1.45± 0.57). This suggests that
VL can be established in naive regions of India more easily than in naive regions of
Sudan. The parameter sensitivity analysis on RC suggests that the average biting
rate and transmission probabilities between host and vector are among the most sen-
sitive parameters for both countries. The comparative assessment of VL transmission
dynamics in both India and Sudan was carried out by parameter sensitivity analysis
on VL-related prevalences (such as prevalences of asymptomatic hosts, symptomatic
hosts, and infected vectors). The results identify that the treatment and symptoms’
developmental rates are parameters that are highly sensitive to VL symptomatic and
asymptomatic host prevalence, respectively, for both countries. It is found that the
estimates of transmission probability are significantly different between India (from
human to sandflies with mean of 0.39 ± 0.12; from sandflies to human with mean
0.0005 ± 0.0002) and Sudan (from human to sandflies with mean 0.26 ± 0.07; from
sandflies to human with mean 0.0002± 0.0001). The results have significant implica-
tions for elimination. An increasing focus on elimination requires a review of priorities
i
within the VL control agenda. The development of systematic implementation of con-
trol programs based on identified risk factors (such as monitoring of asymptomatically
infected individuals) has a high transmission-blocking potential.
ii
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Chapter 1
GENERAL INTRODUCTION AND OVERVIEW
1.1 About This Thesis
This dissertation is driven by my desire to ameliorate the impact of neglected
infectious diseases at the population level. I have chosen to focus on VL not only
because of the lack of political interest in reducing its prevalence but also, because I
had an opportunity to gather, assess, and analyze data from two of the most affected
countries of the world: India and Sudan. This dissertation is organized into four
chapters. In the remainder of this chapter, I review the epidemiology of Leishmaniasis,
with emphasis on the spread of Visceral Leishmaniasis in India and Sudan. Chapter 2
presents two VL-related data sets obtained from the literature and a novel procedure
to estimate parameters of a mathematical model that captures transmission dynamics
of VL and the risk associated with its spread. In Chapter 3, estimates from Chapter
2 are used to carry out a comparative study of VL dynamics between India and
Sudan. Notably, the comparative analysis identifies and assesses country-dependent
risks related to the spread and maintenance of VL. Some mathematical details of
VL transmission dynamics model are collected in Chapter 4. The dissertation ends
with the collection of implications from this study on VL transmission dynamics in
Chapter 5.
1.2 Epidemiology of Leishmaniasis
Leishmaniasis refers to a range of complex vector-borne diseases caused by para-
sitic protozoa parasites (Kinetoplastida: Trypanosomatidae) from the genus Leishma-
1
nia (Subgenus Leishmania and Viannia), which naturally multiply within a vertebrate
host and are transmitted between hosts by the bites of infected female phlebotomine
sandflies (Diptera, Psychodidae: Phlebotominae). Occasionally, non-vector transmis-
sion occurs congenitally or via by blood transfusion or needle sharing (118). The
leishmaniases are endemic to 98 countries throughout the tropics and sub-tropics and
currently affect more than 12 million people worldwide, with an additional 350 mil-
lion people thought to be at risk of infection (152). The incidence of clinical cases
is at an all-time high (between 1.5 and 2.5 cases) with more than 1.3 million new
cases diagnosed annually (including 500,000 new cases of VL) (97; 152). Moreover,
the world’s leishmaniasis prevalence is between 10 and 12 million, a number that may
not represent the actual burden of the infection because cases are often misdiagnosed
or unreported.
The majority of those at risk are from developing countries and are among the
poorest people in society, where leishmaniasis is associated with poor socio-economic
status, malnutrition, illiteracy, population displacement, gender discrimination, poor
immune status (6), and, increasingly, urbanization (39). The World Health Organiza-
tion (WHO) has designated leishmaniasis as one of the “Neglected Tropical Diseases
(NTD)” (154). The World Health Assembly approved a resolution in 2007 that aimed
at improving awareness of leishmaniasis, standardizing diagnosis, and evaluating cur-
rent medicines, [increasing access to affordable healthcare through cost reduction
policies directed at drug-producing laboratories] (151).
The epidemiology of leishmaniasis is highly complex, diverse, and distributed
worldwide with marked regional differences in vector and parasite species, transmis-
sion routes, environments, reservoirs, and clinical profiles. It can be anthroponotic
(human reservoir) or zoonotic (animal reservoir), depending on different vertebrate
hosts. Four major eco-epidemiological profiles have been recognized: zoonotic and an-
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throponotic visceral leishmaniasis (ZVL and AVL) and zoonotic and anthroponotic
cutaneous leishmaniasis (ZCL and ACL).
Depending on the etiological agent, the course of the disease is variable, ranging
from ulcerative lesions of the skin or facial mucosa, known as Cutaneous Leishma-
niasis (CL) and Mucocutaneous Leishmaniasis (MCL), to a lethal systemic disease,
Visceral Leishmaniasis (VL), which primarily affects the internal organs and is usu-
ally fatal in the absence of treatment (52; 72; 107). Fewer common clinical disease
manifestations include diffuse cutaneous leishmaniasis (DCL) and post kala-azar der-
mal leishmaniasis (PKDL), whereby nodular skin lesions appear all over the body
(41; 76; 120). Though these two may seem similar, DCL is a clinical manifestation
associated with CL-causing parasite species whereas PKDL is a cutaneous episode
that follows the resolution of VL infection and it is mainly six months in Sudan and
two to three years in India (110; 157).
Geographically, the distribution of leishmaniasis is complex with a taxonomy of
20 different species of Leishmania. The geographic occurrence is classified into Old
World and New World leishmaniasis with infections occurring in humans and many
domestic animal species. Old World leishmaniasis takes place in Africa, Asia, Middle
East, Mediterranean Basin and clinically appears as cutaneous or visceral disease
(85). New World leishmaniasis occurs in Central and South America and is caused
by Leishmania species and occurs clinically appears as cutaneous, mucocutaneous, or
visceral disease (85).
Infection by the leishmania protozoa is acquired primarily when an infected female
sandfly bites a susceptible individual. There are many strains of Leishmania protozoa
transmitted by two genera of sandflies. In the Old World, the sandfly vector is of the
genus Phlebotomus, whereas in the New World, it is of the genus Lutzomyia (83; 148).
Of these two genera, more that 30 species of sandfly can support the development of
3
leishmania in their guts and pass the pathogen to humans (29).
Leishmaniasis disease manifests in three forms: cutaneous (diffuse cutaneous, re-
cidivans, or post-kala-azar dermal leishmaniasis), mucocutaneous, visceral, and vis-
cerotropic forms.
1. Cutaneous leishmaniasis (CL): CL is also known as “Baghdad Boil,” “Ori-
ental Sore,” or “Uta,” and it is the most common form of leishmaniasis. It causes
skin lesions, mainly ulcers, on exposed parts of the body, leaving life-long scars
and serious disability. Once infected with leishmania protozoa, a person enters
an incubation period lasting between a week and several months during which
no physical symptoms are presented (8; 34). When the incubation period is
complete, multiple lesions form on the skin, often in exposed areas that have
been targeted by sandflies. Parasites also persist at the original site of infection
for many years, leading to concomitant immunity but also relapse.
About 95% of CL cases occur in the Americas, the Mediterranean basin, the
Middle East and Central Asia. More that two-thirds of new CL cases occur in 6
countries: Afghanistan, Algeria, Brazil, Colombia, the Islamic Republic of Iran,
and (34). An estimated 0.7 million to 1.3 million new cases occur worldwide
annually.
Cutaneous leishmaniasis may be either anthroponotic (having humans as the
sole host) or zoonotic (having another species as the primary reservoir). In
areas of the Middle East and North Africa, cutaneous leishmaniasis is caused
by leishmania and is mainly zoonotic. Its main reservoir is rodents, such as
the great gerbil Rhombomys opimus and the fat sand rat Psammomys obesus
(8). Leishmaniasis caused by Leishmania Brazilians in Brazil is also zoonotic
and principally infects either rodents or dogs bitten by the sandfly Lutzomyia
4
whitmani. Human case numbers are especially high in drier areas in the north-
east Brazil, where the absence of dense vegetation seems to increase sandfly
prevalence. Anthroponotic cutaneous leishmaniasis is found in the drier west-
ern parts of India and in Afghanistan, where disease is commonly caused by
Leishmania tropica spread by the sandfly Phlebotomus sergenti (152).
2. Mucocutaneous Leishmaniasis (MCL): MCL leads to the partial or de-
struction of mucous membranes of the nose, mouth, and throat, sometimes
occurring years after the first bout of cutaneous leishmaniasis. MCL is caused
by Leishmania protozoa colonizing macrophages in the nasopharyngeal mucosa
(29). Similar to other forms of leishmaniasis, clinical progression is dependent
on the immune response of the host and on the strain of leishmania with which
they are infected. Almost 90% of mucocutaneous leishmaniasis cases occur in
the Plurinational State of Bolivia, Brazil, and Peru.
3. Visceral Leishmaniasis: VL occurs in Central and South America, the Mediter-
ranean basin, Central Asia, the Indian subcontinent, the Middle East, and
Africa. In Asia and Africa, VL is caused mainly by Leishmania (Leishma-
nia) donovani and is transmitted by Phlebotomus (Euphlebotomus) argentipes
in Asia and P. (Larroussius) orientalis and P. (Synphlebotomus) martini in
Africa (83; 117).
Humans act as reservoirs (Anthroponotic Visceral leishmaniasis). In the Mediter-
ranean basin, Leishmania (L.) infantum is responsible for VL and it is trans-
mitted mostly by P. (La.) Perniciosus and P. (La.) ariasi. Dogs are the main
reservoirs (Zoonotic Visceral Leishmaniasis). In the New World, L. (L.) in-
fantum(syn L. chagasi) is the causative parasite and Lutzomyia (Lutzomyia)
longipalpis is the primary vector with dogs, foxes (117; 83) and jackals as reser-
5
voirs.
Cells of the reticuloendothelial system are the target of the parasite, causing
fever, weight loss, hepatosplenomegaly, and pancytopenia with anemia, throm-
bopenia, and immunosuppression. Lymphadenopathy is common in Sudan, and
hyperpigmentation is observed in Indian patients with prolonged disease (kala-
azar, “black fever” in Hindi). Occasionally, a cutaneous form of the disease
appears, usually post-treatment, with multiple nodular lesions, in particular on
the face, called post-kala-azar dermal leishmaniasis (PKDL). PKDL is unpre-
dictable and variable, occurring in 50% of treated patients in East Africa and
5-15% of treated patients in India (153).
Diagnosis and Treatment: Both parasitological and immunological techniques
are used for leishmaniasis diagnosis. Clinical differential diagnosis includes tuber-
culosis, carcinoma, and dermatomycoses in CL and malaria, syphilis, tuberculosis,
typhoid fever, brucellosis, histoplasmosis, and schistosomiasis in VL. Parasitologi-
cal techniques for Leishmania detection include a direct microscopic examination of
Giemsa-stained skin biopsies, scrapings, and impression smears for both CL and MCL,
and aspirates from lymph nodes, bone marrow, liver, and spleen for VL (137).
To detect and identify leishmania, amplification of leishmania DNA by polymerase
chain reaction (PCR, PCR-RT, PCR-RFLP) is a useful diagnostic method (37); how-
ever, it is expensive for developing countries and technically demanding. Molecular
techniques are also used to quantify parasite load, treatment monitoring, determina-
tion of virulence or drug resistance and parasite tracking in epidemiology.
Immunological techniques include Montenegro (leishmanin) skin test (Delayed
Type Hypersensitivity), antigen detection in urine (by latex agglutination), sero-
diagnosis by indirect immunofluorescence and enzyme-linked immunosorbent assay
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(ELISA). Rapid methods such as rK-39 ICT (Immunochromatography) and DAT
(Direct Agglutination Test) are also used (125; 2). At present on the Indian sub-
continent, rK-39 ICT (Immunochromatographic nitrocellulose strips test) based on
serum or finger-prick has been introduced with the aim to diagnose VL earlier (131).
However, it is invasive and requires phlebotomists and sterilized needles. Because
of the high proportion of refusals from children and healthy persons, great difficulty
arises in sampling blood; as an alternative, rK39-based immunochromatographic test
(ICT) has been suggested.
First-line treatment for visceral leishmaniasis is pentavalent antimonials (Sodium
Stibogluconate-Pentostam and Meglumine antimoniate-Glucantim), Amphotericin B,
(Fungizone and its liposomal formulation AmBisome) and Pentamidine (28; 142).
Despite their toxicity, antimonials are widely used, but treatment failure has been
reported especially in Bihar (> 60%) and Sudan. For CL, pentavalent antimonials
are the first choice and miltefosine, topical paromomycin, imiquimod, or antifungal
azoles, are also used (33).
Control and Prevention: Due to the lack of available and efficient treatment
means different control techniques have been introduced which target disease preven-
tion. Leishmaniasis control is complicated due to the geographic diversity of vectors,
parasites, and reservoirs as well as the limitation to identify breeding and resting
sites.
Some general control methods for leishmaniasis include the application of in-
secticides and insect repellents, covering exposed skin, and avoiding contact with
known disease reservoirs. For example, in India, the National Kala-Azar Elimina-
tion Program is based on Integrated Vector Management including Indoor Residual
Spraying (IRS) of houses and cattle sheds (130), personal protection using insec-
ticide treated nets (ITN) (99), and micro-environmental management (106). DDT
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(dichlorodiphenyl-trichloroethane), is the primary insecticide used in Bihar (one of
the most VL epidemic zones) due to low cost; however, the sandfly in India, Phle-
botomus argentipes (Diptera: Psychodidae), is becoming resistant (19). Culling dogs
have been trialed as a control in Brazil but were only effective when incorporated
with other control techniques. In some regions, new dogs replaced those culled so
quickly that the effect of culling alone was small, and the reservoir soon replenished
(38).
One of the current focal points for leishmaniasis research is the engineering of
suitable vaccines for both cutaneous and visceral strains. The antigenic variety of
the different strains coupled with the complex life cycle of the leishmania protozoa
make the development of a vaccine complicated, and results obtained so far have
not yet proven sufficcently successful (66). Sandfly control is key for leishmaniasis
control, helping also with the reduction of biting nuisance, control of Carrion’s disease
(Borrelia bacilliformis), and arboviruses transmitted by sandflies in endemic areas
(117).
Epidemiology of Visceral Leishmaniasis(VL) and global burden: VL is a
fatal vector-borne parasitic disease thought to infect an estimated 500,000 new cases
annually and to cause about 57,000 deaths worldwide each year (52; 72; 97). It
constitutes a serious public health risk in countries throughout the tropics, subtropics,
and the Mediterranean basin, especially those countries that are the least developing
in the world. More than 90% of VL transmission occurs in five countries: Nepal,
India, Bangladesh, Sudan, and Brazil (north-eastern region) (72; 97; 141; 143), where
the burden of the disease falls most heavily on the poor and young (children less than
ten years old).
India alone accounts for almost 50% of the global VL disease burden, with an
estimated annual incidence of 100–200,000 (36). Within India, the northeastern state
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of Bihar accounts for 90% of all reported cases of VL, contributing approximately
half of the world’s annual new cases (67; 147; 102), with 30 districts within the state
classified as endemic and an estimated 67.5 million people at risk of acquiring VL
(35). India, Nepal, and Bangladesh – three VL-endemic countries – were committed
to eliminating VL as a public health problem from the region by 2015. Their fail
to meet the target to reduce the annual VL incidence to less than one new case per
10,000 inhabitants in all endemic districts (112).
VL causes the loss of thousands of lives and prolonged morbidity, posing a tremen-
dous challenge to both public health and the social and economic development of Bi-
har (133). The actual disease load in Bihar is considered to be significantly higher as
a result of under-reporting to government health authorities (35; 134; 4), and uniden-
tified reservoirs in endemic foci (4; 134), with some estimates suggesting incidence
is 2-2.5 times higher than recorded incidence and five times higher than officially re-
ported cases (147; 4). The shifting geography and epidemiology of VL in Bihar has
seen increasing rates of VL in urban settings, despite historically being considered a
predominantly rural disease. Notwithstanding the success of several historical control
programs, increased and sustained transmission has raised questions about the level
of asymptomatic infection in urban populations and its role in maintaining a reservoir
that contributes to re-emerging infection and endemic disease burden in cities.
History of Visceral Leishmaniasis Epidemic: Focal and sporadic cases of VL
have been observed in the majority of Bihar districts since 1977, when effective surveil-
lance systems were first able to capture the VL disease burden in the state (145). The
resurgence of endemic VL came from a point of near total eradication in the 1950s,
with the large-scale “Malaria Eradication Programme” in the Gangetic Basin, reduc-
ing VL significantly. Susceptible to the same insecticides as the Anopheles mosquito,
the malaria vector, the DDT (29) and its impact on the sandfly population high-
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lighted the susceptibility of the VL transmission cycle to well-executed control mea-
sures. Similar eradication programmes were also undertaken in 1991-92 and again
showed positive results, but funding was discontinued after three years with a signifi-
cant number of asymptomatic individuals serving as a reservoir for the resurgence of
infection (29).
Responding to concerns regarding the discontinuation of funding from the State
Government of Bihar and the subsequent increased VL prevalence, the Indian Min-
istry of Health assumed central government control for the VL “Eradication Pro-
grammes” in 2005. Responding to the scale of VL infection throughout the Indian
subcontinent, including significantly increased prevalence in urban areas of Bihar,
India also co-signed a memorandum of understanding with Nepal and Bangladesh to
undertake additional measures to eliminate the disease as a public health problem,
in conjunction with the World Health Organization, by 2015 (102; 29).
VL transmission in the Indian subcontinent is anthroponotic, human-sandfly-
human cycle of transmission via subsequent blood meals of a sandfly. The causal
agent and vector is the parasite Leishmania donovani, transmitted by female Phle-
botomus argentipes sandflies. The geographical distribution of leishmaniasis is linked
to some factors relating to its vector: the abundance and presence of infected sand-
flies, sandfly life cycle, and parasite reservoirs (97). Climate, living conditions, and
socioeconomic status are associated with increased sandfly density (97; 90; 74), as are
conditions commonly found in urban Bihar, including thatched housing constructed
with mud, insecure structures, damp floors, poor sanitation, and the presence of do-
mestic animals and animal dung. The number and density of Phlebotomus argentipes
sandflies are seasonal, correlated with outside temperature and rainfall (111). They
are predominantly peridomestic (46; 111) and are disproportionately found in areas of
high social and economic deprivation (90; 18; 7). In addition to anthroponotic trans-
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mission, there have also been small but significant reports of transmission through
unscreened blood transfusions and transplacental transmission (132; 133).
Asymptomatic L. Donovani Infection: L. donovani infection leading to clinical
VL is suspected to be present in only a small percentage of the infected population,
with a large majority of L. donovani infections not leading to overt clinical disease
(133; 35; 113). Many cross-sectional surveys based on serological testing show sig-
nificant numbers of positive individuals who have never reported clinical disease or
progressed to VL in Bihar (105; 61). The actual number of the proportion of L.
donovani infections that results in clinical VL are poorly documented due to an ab-
sence of the required large prospective epidemiological studies and the difficulty of
assessing the actual level of asymptomatic infection in VL-endemic areas. As humans
are the only reservoir for the parasite (35), any successful control program must pro-
vide appropriate management for both symptomatic and asymptomatic individuals.
As such, further information regarding the role of asymptomatic infection in how
infected individuals will develop VL, and its role in the transmission of VL in Bihar,
is required. For a summary of the life cycle of the Leishmania donovani parasite, see
(72); for a summary of the Leishmania Donovani Life Cycle in and human host, see
(72)
Ross-Macdonald model: In 1902, Sir Ronald Ross was awarded the second Nobel
Prize in Medicine and Physiology for his co-discovery of the life-history of malaria.
His contribution not only increased our understanding of the dynamics of this deadly
parasite(Plasmodium falciparum), but it also allowed the scientific community, par-
ticularly the public health community, to raise new questions. Perhaps the most
important one was, “Can we ameliorate the impact of malaria at the population level
now that we understand vector-host-vector and host-vector-host transmission?”. Ross
began to address this issue with the help of his model, the first nonlinear model for
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the dynamics of vector-borne diseases. A critical conclusion of his model, later mod-
ified and applied by George Macdonald 1957, was that it was enough to bring the
vector populations below some critical threshold to improve, and possibly eliminate,
malaria.
The Ronald Ross- Mac Donald model, is summarized by the following system
dx
dt
=
(
ab
M
N
)
y (1− x)− rx
dy
dt
= ax (1− y)− µy
(1.1)
where x denotes the proportion of infected humans, y the proportion of infected
mosquitoes, a the per-capita mosquito biting rate, b the per-bite of mosquito to human
transmission probability, c the per bite human to mosquito transmission probability,
r the per-capita individual recovery at rate, and µ the per-capita mosquito death
rate.
Critical to this effort is the identification of the basic reproduction number,
R0 = a
2bcM
N
µr
(1.2)
which gives the average number of secondary infections generated by a vector(host)
on the vector(host) population.
This model started the field of mathematical and computational epidemiology
(26). It allowed for the beginning of the mechanism responsible for the transmission
dynamics of malaria. Years later as noted in the 1911 paper of Ross, this work would
be expanded to the study of Sexually transmitted diseases in humans (Cooke and
York 1973, (32); Hethcote and Yorke 1984, (156)).
The models used in this dissertation are the offspring of the Ross-MacDonald
model. We make particular references to the models of Christopher Dye (50; 49; 51;
48) and Anuj Mubayi, et al., (97).
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This dissertation concentrates on extensively reviewing, collecting, and establish-
ing parameter estimates to study VL in varying geographic regions, which is instru-
mental (or vital) to the public health approach to control. The following chapter
carefully drives and incorporates the epidemiological features of VL that are signifi-
cant to study the disease dynamics at a population level on a daily time scale. All the
events between humans and sandflies are evaluated to construct a model that reflects
the disease transmission process. The main contribution of the chapter is to establish
a model for VL that captures the epidemiological dynamics of interacting human and
sandfly populations.
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Chapter 2
RISK FACTORS FOR HYPERENDEMIC VISCERAL LEISHMANIASIS
2.1 Introduction
Visceral Leishmaniasis is the most severe form of the Leishmaniasis family of dis-
eases because death is inevitable if untreated (123). Each year, there are an estimated
500,000 new cases and approximately 50,000 recorded deaths worldwide within the 1
to 2 million newly reported VL cases (40).
A mathematical model is used here to identify factors that may affect the dynamics
of VL given that we have access to datasets that allow us to carry out these analyses.
The control reproductive number (RC), rather than the basic reproduction number,
is estimated and is used to measure the disease’s ability to colonize in a VL naive
population and to estimate the level of endemicity in the presence of treatment, a long-
standing practice in hyperendemic areas. The model guarantees disease persistence
when RC > 1. The case when RC < 1 corresponds to disease eradication (149).
There have been limited studies of the dynamics of VL using mathematical models.
In 1988, Christopher Dye and Daniel M. Wolpert introduced what appears to be the
first anthroponotic VL deterministic model for capturing the temporal dynamics.
Their model was used to explain the observed VL inter-epidemic periods between
1875 and 1950 in Assam, India. Dye, C. et. al, (1992; 1996) later assessed the
impact of control measures in endemic areas using appropriately modified models
(49; 51; 48). The authors concluded that the observed dramatic upswing in VL cases
might be attributed to “intrinsic”(host and vector dynamics birth, and death rates,
immunity) factors (50). Recent studies have quantified the spatial distribution of
14
underreporting levels for VL in India (97).
The current study focuses exclusively on the transmission dynamics of VL in an
area where control practices are common and long standing. The approach simplifies
the epidemiology and considers two disease stages, asymptomatic and symptomatic.
Since VL is hyperendemic in the regions considered, a model with traditional treat-
ment is considered, as it captures the status quo. This is an essential assumption,
since untreated individuals die relatively quickly. Parameters (transmission, death
rates, etc.) are estimated for the VL model system under the per-capita treatment
denoted by θh.
Here, we review the literature on VL data, estimate parameters for selected dis-
tributions for VL epidemiological parameters, and identify risk factors that may be
crucial to the dynamics of VL.
2.2 Methods and Materials
2.2.1 Modeling Framework
The Leishmania donovani transmission cycle is anthroponotic and takes place
from human to human via the bite of an infective female phlebotomine sandfly. A
mathematical model of the transmission dynamics of VL infection is used here where
the interacting populations of hosts and vectors are assumed to mix homogeneously.
Nh(t) denotes the density of humans and Nv(t) the density of sandflies. The trans-
mission dynamics of VL between populations is shown schematically in Figure 3.1.
The dynamics within the human population are modeled using five compartments in-
corporating the number of susceptible individuals (Sh(t)), asymptomatic individuals
(Ah(t)), individuals infectious with VL (Ih(t)), hospitalized individuals (Th(t)), and
recovered-immune to reinfection (Rh(t)); Nh = Sh +Ah + Ih + Th +Rh. The sandfly
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population is assumed to be divided into susceptible (Sv(t)) and infectious (Iv(t)),
with Nv = Sv + Iv. The equations are:
dSh
dt
= Λh − λvhSh − µhSh
dAh
dt
= λvhSh − (φh + µh)Ah
dIh
dt
= φhAh − (θh + µh) Ih
dTh
dt
= θhIh − (γh + µh)Th
dRh
dt
= γhTh − µhRh
(2.1)
dSv
dt
= Λv − λhvSv − µvSv
dIv
dt
= λhvSv − µvIv
(2.2)
Some of The Risk Factors Captured in the Model
Ecological Parameter
Daily exposure to sandfly bites b
Proportion of sandfies that successfully land on human host `
Natural mortality of sandfies µv
Epidemiological Parameter
Average time of treatment φ
Average duration of asymptomatics θ
Transmission probability of sandfly to human given a bite βvh
Transmission probability of human to sandfly given a bite βhv
Demographic Parameter
Natural mortality in the human host µh
Table 2.1: Risk Factors Associated With Demographic, Epidemiological, Ecological
Factors.
Disease-induced mortality is not included because, due to institutionalized treatment,
deaths from VL are negligible. For simplicity, the human population is assumed to
be constant. Λh denotes the recruitment rate into the susceptible population, and µh
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Figure 2.1: A Schematic Representation of The Mathematical Modeling Framework
Consisting of Interacting Human(Nh) and sandfly(Nv) Population. Arrows Represent
Transition Between Different Infection Stages in the Two Populations.
denotes the per-capita death rate. Because Nh approaches Λhµh when t approaches ∞,
we assume, without loss of generality, that Nh = Λhµh (25). A susceptible individual
acquires the Leishmania Donovani parasite following an effective contact with an
infectious sandfly. The rate λvh, the force of infection on humans, is given by
λvh = bβvh
Nv
Nh
Iv
Nv
= bmv:h βvh
Iv
Nv
, (2.3)
where the right-hand expression (Equation 2.3) is given by the product of the per-
vector daily biting rate of sandflies (b), the VL infection transmission probability,
given a bite from an infected sandfly to human (βhv), the average number of sandflies
per humans mv:h, and the proportion of infectious sandflies in the vector population
(Iv/Nv). It is assumed that all newly VL-infected humans go through a asymptomatic
(symptomless) stage (Ah). After an asymptomatic period of several months, humans
develop clinical symptoms at the per capita rate φh, moving to the infectious class Ih.
During the infectious period, humans will seek VL treatment at the per capita rate
θh, proper treatment leads to recovery at the per capita rate γh (recovered individu-
als gain lifelong immunity). Newly emerging adult female sandflies are recruited into
the susceptible population at rate Λv and die at the per-capita rate µv. The sandfly
population is assumed constant. A susceptible sandfly is infected following an effec-
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tive contact with infectious humans at the per capita rate λhv (force of infection on
sandflies). The rate λhv is given by
λhv = bβhv
Ih
Nh
, (2.4)
where the right-hand side is the product of: the per vector daily biting rate (b); the
probability that susceptible sandflies acquire the Leishmania parasite while feeding
on a VL-infected individuals (βhv); the proportion of VL infectious humans in the
human population (Ih/Nh). It is also assumed that the Leishmania parasite has no
impact on an infected sandfly’s lifespan; the sandflies’ natural mortality per-capita
rate is the same for infected and uninfected, namely, µv. See Appendix A for complete
model derivation.
2.2.2 Incidence as a Function of the Landing Rates
We use landing rate data to estimate the transmission probabilities from sandfly to
humans (βhv) and humans to sandflies (βhv). The section provides a careful derivation
of incidence rates, as a function of landing and biting rates, using data on the landing
rates.
The human incidence rate is a function of the average contact rate, which in turn
is directly proportional to the proportions of infectious sandfly
(
I∗v
N∗v
)
. Letting b denote
the average number of bites per sandfly per unit time and ρ the average number of
bites received per human per unit time, and assuming that all sandfly bites are to
humans only, we must have that the total number of bites made by all sandflies per
unit of time (bN∗v ) equals the total number of bites received by all human hosts per
unit of time (ρN∗h). Thus, we have that
bN∗v = ρN∗h ⇒ ρ = b
N∗v
N∗h
, (constant by assumption) (2.5)
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(a) Sandfly on Humans (b) Human to Sandflies
Figure 2.2: Illustration of the Possibilities of Success and Failure of Transmission
of VL Infection: 2.2a From Sandfly to Humans and 2.2b From Human To Sandflies.
Green Depicts Infection While Red Depicts Non-Infection. Human In (A) And Sand-
fly (B) Represent Missing Transmission Rates.
The assumption that ρ is constant is customary in the literature because the host
vector ratio is not, in general, constant over time (but see (150)). We further assume
that the average total number of bites received by a human per unit time is directly
proportional to the sandfly landing rate ` (ρ ∝ `). Based on the fact that contacts
between susceptible host and susceptible vector populations do not result in infection,
we consider only the terms where the contacts are between susceptible host/vector
and infected vector/host populations. Because the total effective landing/feeding of
vectors on a susceptible human is a function of the total vector population, which
includes both susceptible and infected vectors, we can assume that the transmission
rate is given by
βvh`
(
Sv
Nv
+ Iv
Nv
)
Sh, (2.6)
where βvh is the per-person transmission efficiency (i.e., probability that infection is
successfully transmitted from vector to human given an infected bite). Note that
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βvh` is the number of effective landings per unit time, while βvh` IvNv is the proportion
of bites that result in infection. Therefore, βvh` SvNv is the proportion of bites that
get “wasted” since they cannot generate infections, as illustrated in Figure 2.2a.
Similarly, we can derive the infection rate in the vector population generated by
infected humans. If we let βhv be the per-person transmission efficiency from human
to vector (i.e., transmission probability per bite on infectious humans that leads to
infection in a susceptible sandfly), then, given that the average number of landings of
susceptible vectors on the susceptible and infectious humans, we can conclude that
the transmission rate is
bβhv
(
Sh
Nh
+ Ih
Nh
)
Sv, (2.7)
where bβvhSv IhNh is the proportion of bites that result in infection and bβvhSv
Sh
Nh
is the
proportion that do not, and therefore, βvhbSv is the total effective landing/feeding
rate per unit of time (day), as illustrated in Figure 2.2b.
2.2.3 Data Sources
Several data sources are used to generate point estimates and ranges for the model
parameters needed to calibrate our model, which is later used to assess and compare
the potential of VL outbreaks in two hyperendemic areas: India and Sudan. The
epidemiological data, used in calculating the number of yearly cases and deaths,
was obtained from the World Health Organization, the Bihar State Health Society,
and Rajendra Memorial Research Institute of Medical Sciences. Epidemiological and
demographic parameter estimates were taken from the literature and census reports
when available (4; 5; 101). The review of the literature led to two distinct sets of
estimates for some of the VL epidemiological quantities. The parameter estimations
in this chapter are carried out by region involving two data sets (A and B).
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2.3 Analysis
In this section, we derive from the model an expression for the average number of
secondary infections generated by an infected individual (referred here as the control
reproduction number), as well as expressions for the prevalence of different types of the
populations. We also discuss the procedures used for estimating model parameters.
2.3.1 Control Reproduction Number (RC) of VL
The control reproduction number (RC) is defined as the average number of sec-
ondary infections caused by a single infective individual (assumed infectious) when
introduced into a wholly susceptible population of size N ≈ S0 in a system where
treatment (θh) is continuously available (20; 149; 42; 89).
RC is calculated using the next generation operator approach (149; 21; 20) a
process that requires the computation of the matrix of new infection terms F and the
matrix of transition between compartments V. The RC is the spectral radius of the
next generation matrix, ρ
(
FV−1
)
(see Appendix A for a derivation). The control
reproduction number of the model in terms of treatment θh is given by
RC (θh) =
√√√√( φh
(µh + φh)
× βvh`(µh + θh)
)
×
(
bβhv
µv
)
(2.8)
where ` is the landing rate on a human, b is the biting rate per sandfly, and βvh
is the number of infections generated by one infected vector per unit of time. The
expression in Equation 2.8 is referred to as the control reproduction number because
it depends on treatment control, given by the parameter θh. RC (θh) is the geometric
mean of two reproduction numbers
Rhv (θh) = φh(φh+µh) ·
`βvh
(θh+µh) and Rvh =
bβhv
µv
(2.9)
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where Rhv (0) is the number of secondary infections caused in humans by a single
typical infectious sandfly when accessing an entirely susceptible population and Rvh
denotes the number of secondary infections caused in female sandflies by a typical
infected human. RC is the expected number of secondary infections caused by an
infectious human or infectious sandfly over the course of the entire infectious period
in a wholly susceptible population of size Nh ≈ Sh and Nv ≈ Sv, with access to treat-
ment. From point onward we will denote RCI and RCS as the control reproduction
numbers for set A and B respectively.
The analysis of Model (2.1)–(2.2) shows that the model has two equilibria (the
Disease-Free Equilibrium (DFE) and Endemic Equilibrium (EE)).
Remark 2.3.1. The DFE of Model (2.1)–(2.2) always exists and is locally and globally
asymptotically stable (LAS) if RC < 1 and unstable if RC > 1 (see Appendix A.2.3
for proof).
Remark 2.3.2. The EE exists and is locally and globally asymptotically stable only
when RC > 1 (see Appendix A.2.3 for proof).
2.3.2 Parameter Robustness Analysis
We assess risk using RC and endemic prevalences. Studying the sensitivity of
RC with respect to model parameters is critical if we wish to identify the pressure
points of the system; that is, the parameters that are most sensitive, i.e., those
that generate the largest changes in the dynamics sensitive parameters represent
the ideal target points for intervention. Parameter uncertainty (UA) and sensitivity
(SA) analyses are used to assess the robustness of the model results as a function
of the lack of precision in the estimated model parameters. The analyses rely on
Latin Hypercube Sampling (LHS) (Mckay et al., 1979; Blower and Dowlatabadi 1994;
Marino et al., 2008 (94; 17; 92)) and require the computation of the Partial Rank
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Correlation Coefficient (PRCC), a sensitivity index of the output quantities with
respect to each parameter (Marino et al., 2008 (92)). The LHS scheme includes the
generation of a stratified random sampling that ensures a complete exploration of the
feasible parameter space. In the sampling, an input parameter X with a pre-defined
probability distribution function (PDF) is divided into N equiprobable subintervals.
From each subinterval, a value is sampled. The N values for this parameter are
randomly paired with the corresponding N values of every other parameter generated
in the same way. The PRCC is used to measure the degree of linear association
between two parameters from a set of parameters, after the influence of linearity
from all other parameters of the set has been eliminated (92). The calculated PRCCs
and corresponding p-values are used to identify the input parameters sensitivity rank
of the input parameter to the output variable. The PRCC value of each inputed
parameter is considered statistically significant, with p-value < 0.05 if it satisfies
|PRCC| > 0.5.
Multiple data sources and reports were considered as we proceeded to obtain point
estimates for each parameter associated with RC and prevalence expressions from the
model. These point estimates were later used to obtain parameter values for the pre-
selected theoretical distribution used for generating random parameter samples. We
assess the impact of variation in each of the uncertain model parameters and its level
of influence on the estimates of RC as well as its prevalence of different populations.
2.3.3 Parameter Estimation
A thorough review of the literature and field studies on the epidemiology of VL was
conducted and used to identify model parameter estimates and their possible ranges;
we use this information to pre-select a reasonable distribution for each parameters
(87; 54; 138; 155; 45). Because of significant variations in data from the literature,
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two sets of data for parameters were used in this study. We refer to the two sets of
parameters as data set A and data set B (Table 2.2). We developed an estimation
procedure for calibrating parameters (includes parameters related to transmission
probabilities) for which precise data could not be obtained from the literature. In
Section 2.3.4 we provide a detailed discussion that uses the procedures for estimating
transmission probabilities of the model for the two data sets.
2.3.4 Estimating the Transmission Probabilities
Lack of effective surveillance case identification and case management results in
under-reporting and adds to the uncertainties associated with parameter estimates.
A survey of the literature on mathematical epidemiology studies on VL revealed
that data to estimate transmission probabilities of VL is limited. Hence, we derived
two different approaches to estimate transmission probabilities. The two estimation
approaches depend on model-generated expressions for the endemic components of
the endemic equilibrium and the control reproduction number(RC). The endemic
equilibrium is given by
E∗ =
(
Λh (bφh βhvµh +G1G2µv)
bφh (` βvh + µh) βhvµh
,
Λh (R2C − 1)G2µv
bφh (` βvh + µh) βhv
,
A∗hφh
G2
,
A∗hφh θh
G2G3
,
ΛhΛv
S∗hµhµvR2C
,
A∗hφh θh γh
G2G3µh
,
µhβhvbI
∗
hS
∗
v
µvΛh
)
(2.10)
where G1 = φh + µh, G2 = θh + µh, and G3 = γh + µh. The VL infected components
of the endemic equilibrium are:
A∗h =
Λh (b`βhvβvhφh −G2G3µv)
βhv (`βvh + µh)G2bφh
≥ 0 (2.11)
I∗h =
Λh (b`βhvβvhφh −G2G3µv)
βhv (`βvh + µh)G3G2b
≥ 0 (2.12)
I∗v =
Λv (b`βhvβvhφh −G2G3µv)µh
`βvh (bβhvµhφh +G2G3µv)µv
≥ 0 (2.13)
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The data sets A and B for known parameters, prevalence data from the literature,
and expressions I∗h (3.3) and I∗v (3.4) are used to generate estimates (distribution)
for the transmission probabilities (βvh and βvh). The expressions of the components
of the endemic equilibrium (the infectious components, I∗h (3.3) and I∗v (3.4) of the
equilibrium E∗(2.10) )
PIh = I
∗
h
N∗
h
= (b`βhvβvhφh −G2G3µv)µh
βhv (`βvh + µh)G3G2b
(2.14a)
PIv = I
∗
v
N∗v
= (b`βhvβvhφh −G2G3µv)µh
`βvh (bβhvµhφh +G2G3µv)
(2.14b)
are used in developing the estimation procedures.
Approach 1
Fixing all model parameters and assuming that the human and vector prevalences
are known, we isolate βhv and βvh from the equations (2.14a) and (2.14b) and obtain
estimates of the transmission probabilities:
βhv =
µvPIv
bPIh (1− PIv)
(2.15a) βvh =
G1G2PIhµh
`PIv (φh µh −G1G2PIh)
(2.15b)
where βvh is well-defined iff φh µhG1G2 > PIh .
Approach 2
Now suppose the estimate of RC is known. Rewriting the equations 2.14a and 2.14b
in terms of RC , we obtain:
PIh =
µh (R20 − 1)
µhR20 + `βvh
(2.16a) PIv =
(R20 − 1)µh
µhR20 + `βvh
(2.16b)
.
Isolating βvh and βhv from (2.16a) and (2.16b) leads to
βhv =
µvPIv
bPIh (1− PIv)
(2.17a) βvh =
µh (1 + (1− PIv)R20)
`PIv
(2.17b)
.
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Data set A Data set B
Parameters Min Mean Max Min Mean Max
Fixed
b - 2.08 - - 1.6208 -
µh - 4.54e-5 - - 4.3e-5 -
µv - 0.0833 - - 0.0857 -
φh - 0.00975 - - 0.0098 -
θh - 0.0083 - - 0.0143 -
Varied
Ph 0.0024 - 0.0027 0.0013 - 0.0015
Pv 0.0054 - 0.0157 0.054 - 0.037
` 8.68 12.15 17 15.7 32 48.3
RC 1.3 2.0 2.1 1.1 1.3 1.5
Estimates using Approach 1
βhv 0.13 0.3 0.49 0.12 0.25 0.4
βvh 0.0003 0.0008 0.003 4.8e-05 0.00013 0.0005
Estimates using Approach 2
βhv 0.13 0.397 0.49 0.12 0.25 0.4
βvh 0.0004 0.0007 0.001 0.00004 0.00013 0.00016
Table 2.3: Summary of Estimates of the Transmission Probabilities, βhv and βvh,
Using the Two Approaches with Mean and Ranges for Other Parameters (Table 2.2)
for data sets A and B were fixed. Empty cells indicates vlues not used in the procesure.
2.4 Results from Global Uncertainty and Sensitivity Analyses
Parameter uncertainty and sensitivity analyses are performed on the reproduction
number (RC) and the prevalence of the infected populations (PAh , PIh , and PIv).
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Figure 2.3: Estimated Distribution of βvh and βhv, Respectively, for Data Set A,
(a–b) and Data Set B, (c–d). A1(A2) Represent The Distribution Obtained Using
Approach 1(Approach 2). A Visual Comparison of the Fitted Gamma Curve To-
gether with the Model Obtained Estimated Transmission Probabilities Transmission
Probabilities βvh
The analyses used to assess which of the eight input parameters (b, `, βhv, βvh, µh,
µv, φh, and θh) are most relevant for disease dynamics. We assign a PDF to each
of the eight parameters (See Table 2.4). For landing and biting rate of sandflies,
denoted by b and `, respectively, we obtained a triangular distribution by fitting to
field data (shown in the Appendix B). The parameters, βvh and φh were assigned
a gamma distribution based on prior experience (Mubayi et al. (97)). The gamma
distribution was found to be a best fit to the sample estimates of βvh obtained using
28
our estimation procedure and an expression in Equation 3.5a (Figure 2.3b). In the
case of the parameters βhv, θh, µh, and µv we chose a uniform distribution, using
the minimum and maximum estimates from the literature to determine their ranges.
Similarly, for βhv, the sample point estimates generated using Equation 2.15b are
used to obtain a best-fit uniform distribution (Figure 2.3a). For each of the eight
parameters with assigned probability distributions, sample sizes of 10, 000 values were
randomly generated over ten independent realizations. Using LHS technique, for each
of the realizations, we paired the first N samples of the first column with N samples
from the second parameter randomly. After all, eight parameters were paired without
replacement; an LHS matrix was generated with its rows and columns corresponding
to samples and parameters, respectively. Each row of the LHS matrix was considered
to generate one estimate of RC using Equation 2.8. Thus, an N × p matrix was
generated by the LHS method (where p represents number of parameters on which
RC depends), resulting in N samples for RC in each realization.
2.4.1 Assessment of VL Related Parameters for Data Set A
We performed uncertainty and sensitivity analysis on the control reproductive
number RC , the endemic prevalences, PAh , PIh , PIv for data set A.
Uncertainty and Sensitivity Analysis on RCI Using Data Set A
The estimated distribution of RCI from the uncertainty analysis, is shown in Fig-
ure 2.5a. The mean estimate of RCI is found to be 2.1, with a standard deviation
of 1.14. The sensitivity analysis of RCI provides the ranking of parameters based on
their influence on RCI . The parameter ranking in decreasing order of influence shows
that θh, is the most sensitive, followed by `, βhv, βvh, and b; the least sensitive are φh,
followed by µv (Figure 2.5e).
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Uncertainty and Sensitivity Analysis on the Endemic Infected Prevalence
Using Data Set A
We perform uncertainty and sensitivity analyses on the point endemic prevalence for
the infected populations PAh , PIh , and PIv . The estimated distributions of preva-
lence are shown in Figures 2.5b–2.5d. The mean estimate of PAh was found to be
0.0038, with a standard deviation of 0.0025. The parameter φh was found to be the
most influential parameter on the prevalence of asymptomatic individuals, PAh . The
remaining parameters in descending order of magnitude of PRCC are, θh, `, βhv, βvh,
and µv and µh being the least sensitive parameters to PAh . The sensitivity analysis
performed on PIh reveal that the treatment rate θh is the most influential param-
eter when the goal is to change disease prevalence. The mean estimates of vector
prevalence were found to be 0.0054, with a standard deviation of 0.0053. From our
sensitivity analysis of PIv we observe in Table 2.5 and Figure 2.5h, the four most
influential parameters. These parameters, in decreasing order of rank, are θh, βvh, b,
Parameter Data set A Data set B
b T (0.8, 1.6, 2.5) T (0.35, 1.8, 3.4)
` T (0.55, 8.3, 17) T (16, 32, 48)
φh G (5.5470, 0.0021) G (5.2727, 0.0018)
βvh G(7e−5, 7.5e−5) G(6.3e−5, 3.7e−5)
βhv U (0.16, 0.73) U (0.12, 0.42)
θh U (0.0014, 0.0167) U (0.0082, 0.0329)
µh U (4.1e−5, 4.5e−5) U (4e−5, 4.5e−5)
µv U (0.0667, 0.1250) U (0.071, 0.1)
Table 2.4: Initial Assigned Distributions of the Model Parameters for Data Sets A
and B. Where Triangular: T (min,mode,max), Gamma: G(shape, scale), and Uni-
form: U (min,max).
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and µv.
Output RCI PAh PIh PIv
Rank Parameter PRCC Parameter PRCC Parameter PRCC Parameter PRCC
1 θ −0.88 φ −0.87 θ −0.95 θ −0.96
2 ` 0.83 θ −0.66 ` 0.56 βvh 0.89
3 βhv 0.80 ` 0.57 βhv 0.55 b 0.77
4 βvh 0.76 βhv 0.55 βvh 0.49 µv −0.69
5 b 0.58 βvh 0.50 b 0.33 µh 0.17
6 µv −0.49 b 0.34 µv −0.27 ` −0.03
7 µh 0.01 µv −0.27 µh 0.11 φ −0.01
8 φ 0.004 µh 0.13 φ −0.01 βhv −0.01
Table 2.5: Shows the PRCCs by Rank of Importance for the Input Parameters of
the Output Value RC , PAh , PIh , and PIv for Data Set A. (*) Denotes PRCCs that
are Non-Significant.
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Figure 2.4: Parameter Distributions Conditional onRC > 1 for Data set A Obtained
from Uncertainty Analysis of the Prevalence
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Figure 2.5: Uncertainty Analysis of the (2.7a) Reproduction Number and the (2.7b
–2.7d) Prevalence of Asymptomatics, Infectious Humans and Infectious Sandflies,
Respectively. Tornado Plot Showing Partial Rank Correlation Coefficients (PRCCs)
of the (2.7e) Reproduction Number and the (2.7f –2.7h) Prevalence in Asymptomatics,
Infectious Humans and Infectious Sandflies, Respectively.
2.4.2 Assessment of VL-Related Parameters for Data Set B
Similarly, we performed uncertainty and sensitivity analysis on the control repro-
ductive number RCS and the endemic prevalences PAh , PIh , PIv for data set B.
Uncertainty and Sensitivity Analysis on the Control Reproduction Num-
ber (RCS) Using Data Set B
The results of the uncertainty analysis on RCS are shown in Figure 2.7a, where the
mean estimate of RCS is 1.45, and the standard deviation is 0.57. From Table 2.6 and
Figure 2.7a, we observe ranking of each parameter based on its sensitivity on RCS . In
decreasing order: b, βhv, θh, βvh, and `. The first negatively correlated parameter was
θh, which indicated that measure in estimates of treatment will result in a decrease
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in RCS estimates. The top two most positively sensitive parameters to RCS were βhv
and b.
Output RCS PAh PIh PIv
Rank Parameter PRCC Parameter PRCC Parameter PRCC Parameter PRCC
1 b 0.88 φ −0.83 θ −0.92 θ −0.92
2 βhv 0.87 βhv 0.66 βhv 0.72 b 0.91
3 θ −0.86 θ −0.65 b 0.71 βvh 0.90
4 βvh 0.85 b 0.64 βvh 0.69 µv −0.56
5 ` 0.72 βvh 0.63 ` 0.53 µh 0.21
6 µv −0.43 ` 0.47 µv −0.29 βhv −0.04
7 µh −0.02 µv −0.25 µh 0.12 ` −0.01
8 φ 0.01 µh 0.09 φ 0.02 φ −0.01
Table 2.6: The PRCCs by Rank of Importance for the Input Parameters of the
Output Values of RCS , PAh , PIh , and PIv for Data set B. (*) Denotes p < 0.01.
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Figure 2.6: Estimated Distributions of the Model Parameters Conditional onRCS >
1 for Data set B Obtained from Uncertainty Analysis of the Prevalence
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Figure 2.7: Results for Data set B: Uncertainty Analysis of the (2.7a) Reproduction
number and the (2.7b –2.7d) Prevalence of Asymptomatics, Infectious Humans and
Infectious Sandflies, Respectively. Tornado Plot Showing Partial Rank Correlation
Coefficients (PRCCs) of the (2.7e) Reproduction Number and the (2.7f–2.7h) Preva-
lence of Asymptomatics, Infectious Humans and Infectious Sandflies, Respectively.
Uncertainty and Sensitivity Analysis on the Endemic Infected Prevalence
Using Data Set B
In the case of the asymptomatic prevalence PAh , we estimated its mean value as 0.0024
with a standard deviation 0.0018. The estimated distribution of PAh for data set B
is shown in Figure 2.7b. From Table 2.6 and Figure 2.7f, we observe that the PAh is
negatively correlated and most sensitive to φh, followed by βhv, θh, b, βvh, and `. The
natural death rates, µh and µv in humans and sandflies, respectively, were the least
sensitive input parameters to PAh . From uncertainty analysis on PIh (Figure 2.7c),
we found the average prevalence estimate to be 0.0026, with a standard deviation
of 0.0017. The results of our sensitivity analysis are summarized in Table 2.6 and
displayed in Figure 2.7g, shows that the treatment rate of infectious humans is most
sensitive to changes in θh, which is not surprising. The infection related parameters
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βhv, b, βvh, and ` also play a dominant role on disease persistence. Finally, the
results of the uncertainty analysis on the prevalence of infection in sandflies, PIv , are
shown in Figure 2.7d. The estimated sample mean of PIv is 0.0271, with a standard
deviation of 0.0143. Our analysis identified the parameter’s sensitivity to changes in
PIv (Table 2.6 and Figure 2.7h). The results show that the treatment rate, θh is the
most dominant parameters, followed by b, βvh, and µv. The less influential parameters
on PIv are µh, `, φh, and βvh.
2.5 Discussion
The risk factors associated with VL are complex and ambiguous. In the face of
this uncertainty, the systematic evaluation of ongoing VL elimination programs is
essential. Literature searches were carried out using public health databases, cross-
sectional and cohort studies, government reports, and information from patients at
Rajendra Memorial Institute of Medical Sciences. There was limited available longi-
tudinal data due to a lack of regional publications with information. Further, because
most data studies in the literature did not provide information on participant selection
criteria, did not for confounding variables, and fail to make use of a single diagnostic
test as proof of infection, modeling was our only choice. We used multiple data sets
to get a plausible guess estimate on the ranges of the parameters.
To the best of our knowledge, this is the first study that reviews, evaluates, and
makes use of an extensive collection of available data on epidemiological and ecolog-
ical parameters in the context dynamics of Visceral Leishmaniasis (VL), a project
that identifies risk factors using mathematical models. The objectives of this system-
atic modeling analysis are to detect and classify risk factors for VL use of the best
available field evidence and data. This research may help reduce knowledge gaps of
VL transmission dynamics. The sources of data were used to estimate parameters
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and uncertainty and to address sensitivity light of the selected model. The dynamics
of the model depend on the VL control reproductive number (RC), which measures
the likelihood and severity of an outbreak. The estimated value of the VL control re-
productive number was found to be 2.01 data set A and 1.14 data set B. Uncertainty
analysis on RC also showed that there were eight parameters (see Table 2.2) that
should be taken into consideration when assessing the uncertainty associated with
the risk of increasing levels of VL. The parameter sensitivity analysis on RC suggests
that the biting rate, the average number of vectors per person in a given day, the prob-
ability of infection transmission between vector and humans, and the treatment rate
are the most influential parameters associated with the complex disease transmission
cycle involving sandflies and humans for both countries.
The results are based on the model’s parameter estimates that were collected
or estimated from current and available VL data reports. The study was limited
by available data as well as by the period used to collect the data. Several of the
parameter value we found in the literature.
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Chapter 3
COMPARISON OF RISKS ASSOCIATED WITH VL IN INDIA AND SUDAN
This chapter presents a comparative analysis using our model and available data
of the hyperendemic VL regions in India and Sudan. Specifically, parameter estimates
are used to assess and compare the VL burden in regions in India and Sudan. The
most recent report estimates that there are between 200,000 and 400,000 annual cases
of VL in six countries, with India supporting between 146,700 to 282,000 cases per
year, and Sudan supporting between 15,700 and 30,300 cases per year (14).
In this chapter, we study the impact of risk factors that are critical for surveillance
of VL for India and Sudan. In India, the sandfly species Phlebotomus argentipes is
primarily responsible for transmitting the L. donovani parasite (116). The Indian
state of Bihar is one of the worse affected by VL. In Bihar, cross-sectional studies
have shown that annual patterns of high VL incidence are driven by factors that
include seasonal fluctuations of the sandfly population, lack of health care resources
and extreme poverty (97; 80); Malnutrition has also been shown to be a factor, with
VL outbreaks, verified by studying deviations from the endemic level, occurring in
regions in India where catastrophic events (such as flooding) resulted in food shortages
(5). In Sudan, a variety of studies on vector entomology and epidemiology have been
used to establish that Phlebotomus orientalis is the dominant sandfly vector associated
with anthroponotic L. donovani transmission (155; 126; 68; 69; 55; 58). Typically, P.
Orientalis is considered a forest species, and its abundance is frequently associated
with the presence of the savanna woodland tree species Acacia Seyal and Balanites
aegyptiaca as well as deeply cracked vertisols (black cotton soil) (55; 56). Primary
risk factors for VL infection in Sudan include genetic factors (e.g., some indigenous
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individuals may be more susceptible (5)), age, ethnicity, and poverty (23). Outbreaks
also seem connected to the dynamics of massive population movements in endemic
regions or areas facing war or political instability, accompanied by labor migrations
for economic security reasons (118; 5).
In Bihar, where 90% of India’s VL cases occur, aggressive attempts at improv-
ing vector control programs via the distribution of insecticide-treated bed nets and
insecticide spraying are being carried out (5). India’s Kala-Azar Elimination Pro-
grams (KAEP) aims at reducing VL morbidity and is tied into government-funded
VL diagnosis and drug treatment programs. Pentavalent antimonial drugs, wherever
effective, purchased by the public sector are barely sufficient to cover half of the in-
fected patients (97; 4). The State of Bihar in India reports approximately 270,900
cases every year with an incidence rate of 21 cases per 1000 (72). The state of Bihar
includes 21 districts among the 38 that are most affected in India.
VL is also endemic in southern, central, and eastern Sudan, with 6,957 cases
reported in the state of Gedaref (near the Ethiopian border) during 2010 (82). Limited
drug availability and drug resistance are growing problems in East Africa, particularly
in Sudan, where antimonials are still the primary method of VL medical treatment.
The poor must travel long distances to gain access to drugs and, consequently, the
effectiveness of intervention policies are limited. Infected Sudanese often must wait
extended periods of time before receiving minimal medical care (104). In a field study
conducted by Burza, et al. in 2014, access to treatment was fund to be crucial in
controlling VL (24). In both India and Sudan, the presence of livestock near or in the
household was high risk for VL transmission. The materials used for building homes
in both countries, such as mud and straws, serve as the natural sites for sandfly
breeding.
There are four primary drugs available for VL treatment in Asia and East and
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West Africa. In India and Sudan, the effectiveness of these drugs varies if measured by
treatment outcome, efficiency, and availability (29). The primary drugs for VL treat-
ment in India are liposomal amphotericin B after the first line treatment; pentavalent
antimonial drugs, over the years, became drug resistant to the Leishmania parasite
(86). In Sudan, the two primary drugs for VL are sodium antimony gluconate (SAG)
and Liposomal Amphotericin B (86). In India, a single dose of Liposomal Ampho-
tericin B is sufficient for treatment, but in Sudan higher dose is needed for complete
treatment (29).
The most effective drugs for treating VL require cold storage facilities that are
either missing or only available in limited numbers in VL-affected areas. Poor access
to medical services often translates into low treatment rates in some regions (24).
Additional, factors associated with disease transmission are landing rate, the average
daily biting rate per human, and the transmission probabilities between human and
sandflies. In India, houses with mud-plastered walls, straw houses, and the ownership
and rearing of livestock (such as goats, cattle, buffalo, etc.) are all considered as
high-risk factors for VL (134). The risk may be greater when a large number of indi-
viduals lived with animals (e.g., when animals are kept indoors to avoid theft(134).
Livestock plays a crucial role in attracting sandflies and the increase in VL transmis-
sion probabilities (10). Staying with a family member who had a previous history of
VL has also been shown to be a risk factor (134; 115). One of the major contributing
factors for VL infection in Sudan is living and playing in the dark or in proximity
to forested trees. In Sudan, the P. Orientalis, the primary vector for L. Donovani
transmission, is closely associated with the presence of the Acacia Seyal and Balanites
Aegyptiaca, tree species commonly found in the region (11; 53; 100). Additional risk
factors include houses in proximity to caves, crevices, animal burrows, and termite
mounds where P. Orientalis usually breeds (96).
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RC estimates for India and Sudan, a rough attempt at integrating reported bio-
logical and ecological field data to VL transmission in both countries, are used in the
analysis presented in this chapter. The goal is to compare and contrast quantitative
differences of VL in two ecologically distinct regions of the world, India and Sudan.
The section collects the mathematical tools employed for comparative assessment for
understanding VL dynamics.
3.1 Methods and Material
A model capturing VL transmission dynamics between human and sandfly pop-
ulations is used to compare the risks associated with VL in India and Sudan. The
model includes human and vector epidemiological states and the transition between
states (shown in Figure 3.1). The model variables and parameters are defined in
Table 2.2. The model control reproduction number in terms of treatment θh is
Figure 3.1: A Schematic Representation of the Mathematical Modeling Framework
Consisting of Interacting Human(NH) And Sandfly(NV ) Population. Arrows Repre-
sents Transition Between Different Infection Stages in the Two Populations.
R2C (θh) =
(
φh
(µh + φh)
· βvh`(µh + θh)
)
·
(
bβhv
µv
)
(3.1)
The expression φh(µh+φh) ·
βvh`
(µh+θh) is the average number of new cases vectors generated
by one infected human and bβhv
µv
represents the average number of new cases in humans
produced by one infected vector. The expression in Equation 4.7 is referred to as the
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control reproduction number because it depends on the parameter θh. The model has
two equilibria: the disease free state and the endemic equilibrium. When RC > 1,
the model has stable endemic states that depend on other model parameters.
In the current hyperendemic regions of India and Sudan, we have, at the current
estimated levels of treatment, that RCI (θh) > RCS (θh) > 1. That is, estimates of
the control reproductive number for India RCI (θh) are in general greater than those
of Sudan RCS (θh).
3.1.1 Endemic Equilibrium
The three infected components of our endemic equilibrium derived from our model
express the prevalence of asymptotic humans, symptomatic humans and infected
vectors:
A∗h =
b`ΛhΛvβhvβvhφh −G1G2NhNvµhµv2
βhv φh (`Λvβvh +Nvµhµv)G1b
≥ 0 (3.2)
I∗h =
b`ΛhΛvβhvβvhφh −G1G2NhNvµhµv2
βhv (`Λvβvh +Nvµhµv)G2G1b
≥ 0 (3.3)
I∗v =
b`ΛhΛvβhvβvhφh −G1G2NhNvµhµv2
` βvh (bΛhβhvφh +G1G2Nhµv)µv
. ≥ 0 (3.4)
Using the infectious components of the endemic states, and the control reproduc-
tion number, we get (as in Chapter 2):
βhv =
µvPIv
bPIh (1− PIv)
(3.5a) βvh =
G1G2PIhµh
`PIv (φh µh −G1G2PIh)
. (3.5b)
These expressions of the transmission probabilities are used to obtain their esti-
mates using estimates of RC and estimates of prevalences from literature.
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3.1.2 Data Sources and Sensitivity Analysis
Data on the number of cases for Sudan and India for the 1989 to 2010 period (4; 5)
are shown in Figure 3.2. Data sources on the sandflies’ biting rate were taken from
field studies concentrated on the landing and biting behavior of the P. Argentipes
and P. orientalis (87; 45; 54). In the case of the species of Phlebotomus sandflies,
most of the parameter estimates were taken from data collected via field studies in
parasitology and ecology found in the literature (87; 45; 54). Other epidemiological
data was also collected for India and Sudan.
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Figure 3.2: Trends of Visceral Leishmaniasis Cases in India and Sudan Over the
Past 23 Years (4; 5). The Trends In India is Order In Magnitude Higher Than the
Trends in Sudan. Also Shows Implementation of Major Intervention at Various Time
Points.
Global parameter uncertainty and sensitivity analyses are performed on the Con-
trol reproduction number RC and on the prevalences of symptomatic affected pop-
ulations to assess which of the eight input parameters (b, mh:v, βhv, βvh, µh, µv, φh,
and θh) are most important for disease dynamics and control. We assign a probabil-
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ity density function (PDF) to each of the eight parameters using available data. A
uniform distribution was used along with data from the literature to sample values
for the parameters b, µv, mh:v, βvh, βhv, µh, and µv. The parameters φh, and θh were
sampled from a gamma distribution based on prior experience (Mubayi, et al. (97)).
For each of the eight parameters with assigned probability distributions, sample sizes
of 10, 000 values were generated using LHS technique and randomly paired. For each
8-tuplets of 10,000 sample sets, the outcome variables RC , PAh , PIh , and PIv were
computed using data from the respective countries. The estimated mean value of
RC for India was found to be approximately 2; the average value for Sudan was 1.4.
Determine that India has the highest estimated incidence in the world (146,700 to
282,800/year) doubles Sudan having the highest in Africa (15,700 to 30,300/year)
(5; 4), is not enough unless we can re-scale them appropriately to make any conclu-
sions on differences in RC values. These estimates of RC confirm the current status of
VL in India and Sudan. The difference in the magnitude of RC may be attributable
to the fact that India carries a much greater burden of all new VL cases (almost 50%).
The PRCCs were calculated for each country to quantify the sensitivity of model
parameters on theRC estimates. PRCC values above +5 or below −5 were considered
significant. The parameters b, mhv, βvh, and βhv with positive PRCC values indicate
positive impact the value of RC . The parameter θh plays a negative role on the value
of RC ; that is, an increase in θh results in a decrease in RC estimate.
3.1.3 Statistical Tests
The 2-sample t-test (Two–sample t-test, ttest2, Matlab routine ttest2(x1, x2))
was used to test if mean estimated values representing various VL-related quantities
for the two countries are associated with each other. Following the 2-sample t-test,
non-parametric analysis was conducted to compare estimated distributions of param-
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eters for the two countries using the Kolmogorov–Smirnov test (Kolmogorov–Smirnov
(KS)–test, Matlab routine kstest2(x1, x2)). In both tests, the P − value < 0.05 was
considered significant.
3.2 Results from Comparative Assessment of VL in India and Sudan
Parameter estimates were obtained either from the literature or estimated from
field data, and were used for an evaluation of country-specific risks. The risk quan-
tified differences and similarities in VL disease burden in India and Sudan. In this
section, we conduct the comparative assessment by studying the impact of the change
in parameter estimations on VL disease burden in two countries when risk is measured
either regarding RC or in terms of the prevalence of infection. The final assessment
took into account uncertainty and sensitivity analyses.
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Figure 3.3: A Comparison of Initially Assigned Distributions in Table 2.4 for Model
Parameters (a) b, (b) βvh, (c) βhv, (d) µh, (e) µv, (f) φh, (g) θh and (h) ` Used in the
Sensitivity and Uncertainty Analyses for the Indian and Sudan Populations
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3.2.1 Comparison When Risk is Defined Based on the Control Reproduction
Number
The observed difference in the mean estimate of RCI (≈ 2.01) and RCS (≈ 1.45)
supports the observed higher levels of endemicity (almost more than 40%) in India
compared to Sudan. Statistical tests were carried out to identify any significant
differences in estimated means of RC for India and Sudan (H0 : µ(RCS) = µ(RCI )
against H1 : µ(RCS) 6= µ(RCI ), where the µ represents mean of RCI and RCS). The
analysis suggested rejection of the null hypothesis (Table 3.1); that is, the obtained
point estimates of RC between India and Sudan are statistically different. We also
performed the Kolmogorov-Smirnov test on empirical distributions of RC for both
countries and found that the estimated empirical distributions are not the same.
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Figure 3.4: (a) The Comparison Estimated Distributions of RC for India and Su-
dan. The Box Plot Compares the Mean(◦), Median, Minimum, and Maximum of RC
Estimates for Both Countries. It is Found That the Gamma, is a Best-Fitted Dis-
tribution for the Samples From the Uncertainty Analysis. Table 2.2 Summarizes the
Parameter Fitting for the Gamma Distribution for Both Countries. (b) The Empirical
Cumulative Distributions of the R′s for India and Sudan
The outcome of the sensitivity analysis (shown in Table 3.2 and Figure 3.5) high-
lights differences in the influence of parameters for India and Sudan. In Figures 3.5,
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Comparison between India(I) and Sudan(S)
India(I) Sudan(S)
2-Sample-t-test K–S test
Output
Mean SD Mean SD t–statistic 95% CI KS–statistic
RC 2.10 1.14 1.45 0.56546 50.906 ( 0.624, 0.67397 ) 0.2858
PAh 0.0038 0.0025 0.0025 0.0023 36.8400 ( 0.0012, 0.0013 ) 0.3046
PIh 0.0054 0.0053 0.0026 0.0017 50.3570 ( 0.0027, 0.0029 ) 0.2390
PIv 0.0372 0.0315 0.0271 0.0143 29.2950 ( 0.0094, 0.0108 ) 0.1431
Table 3.1: Statistical Estimates of Quantities, RC , PAh , PIh , and PIv , for VL in
Sudan and India Using the 2 Sample T-Test and Two-Sample Kolmogorov–Smirnov
Test. All Analysis were Found to be Significant, i.e. p < 0.05.
India Sudan
Parameter PRCC(RC) Rank Parameter PRCC(RC)
θ -0.8849 1 βhv 0.8760
` 0.8265 2 b 0.8707
βvh 0.8002 3 θ -0.8567
βhv 0.7610 4 βvh 0.8536
b 0.5841 5 ` 0.7179
µv -0.4898 6 µv -0.4322
φ 0.0093* 7 φ -0.0166*
µh -0.0040 8* µh 0.0122*
Table 3.2: A Comparison of the Partial Rank Correlation Coefficients for Input
Parameters of the Output Value (RC). Where (*) Denotes p < 0.01 for India and
Sudan.
the sign and the magnitude of the PRCC values for each parameter are included.
We observe that the parameters b, `, βhv, βvh, and θh are the most important in
both countries for RC . The parameters b, `, βvh, and βhv with positive PRCC values
indicate positive impact on RC for both countries, while θh plays a negative role.
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Figure 3.5: Tornado Diagrams of Partial Rank Correlation Coefficients, Indicating
the Importance of all Eight Input Parameter’s that Influence the Threshold Quantity
RC . Figure Shows a Comparison of Sensitivity Indices for India and Sudan. In Both
Regions, the Parameters that have PRCC > 0 Indicates an Increasing Influence on
RC Values and Those Having PRCC < 0 will Decrease RC Values.
3.2.2 Comparison When Risk is Defined Based on the Prevalences
Point Prevalence of Asymptomatic Humans (PAh)
Although the level of PAh can be determined when RC is greater than unity, it is
useful to understand the risk associated with increases in the number of asymp-
tomatic individuals. We show that there is a significant difference between the
point prevalence of asymptomatics for India (Mean(SD)=0.0038(0.0025)) and Su-
dan (Mean(SD)=0.0025(0.0023)). There was also a significant difference between the
two distributions of parameters (two-sample Kolmogorov–Smirnov test, p < 0.050).
Combining the results in Sections 2.4.1 and 2.4.2 allows us to compare the results of
sensitivity analysis on PAh for both countries. We observe from Figure 3.6c that the
most sensitive parameters in both countries, in descending order, are φh, θh, `, βvh,
βhv, b, µv, and µh with the least sensitive being µv and µh.
From Table 3.3 and Figure 3.6c, we observed that both countries differ in the
parameter ranking order, with the most sensitive parameter being φh in both. In
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Figure 3.6: Comparison of Uncertainty and Sensitivity Analysis Results on the Equi-
librium Prevalence of Asymptomatics Humans (PIh): (a) Frequency Distributions for
Contributions, (b) Empirical Cumulative Distributions, and (c) Tornado Diagrams of
Partial Rank Correlation Coefficients
India Sudan
Parameter PRCC(PAh) Rank Parameter PRCC(PAh)
φ −0.8709 1 φ −0.8345
θ −0.6600 2 βhv 0.6576
` 0.5731 3 θ −0.6483
βvh 0.5510 4 b 0.6413
βhv 0.4992 5 βvh 0.6260
b 0.3434* 6 ` 0.4671
µv −0.2720* 7 µv −0.2471
µh 0.1255* 8 µh 0.0872*
Table 3.3: A Comparison of The Partial Rank Correlation Coefficients for Input
Parameters of the Output Value (PAh). Where (*) Denotes p < 0.01 for India and
Sudan.
descending order for India, we have θh, `, βvh, βhv, and b, and for Sudan, we have
βvh, θh, b, βhv, and `.
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Point Prevalence of Infected humans (PIh)
There are significant differences between the point prevalence of infected humans
for India (Mean(SD)=0.0054(0.0053)) and Sudan (Mean(SD)=0.0026(0.0017)). For
p-value < 0.05, the two-sample Kolmogorov–Smirnov test concludes that there is a
significant difference between the two distributions (see Figure 3.7a–3.7b). We found
that PIh is most sensitive to θh, `, b, βvh, and βhv and least sensitive to µh, µv and
φh for both countries (Table 3.4 and Figure 3.7c). Both countries have in common
the treatment rate as the most important parameter and µv, µh, and φh (in the same
descending order) as least influential. For both countries, parameter sensitivities are
as follows: For India, in descending order, we have `, βvh, βhv, and b and for Sudan
we have βvh, b, βhv, and `.
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Figure 3.7: Comparison of Result From Uncertainty and Sensitivity Analysis Results
on the Equilibrium Prevalence of Infected Humans (PIh): (a) Frequency Distributions
for Contributions, (b) Empirical Cumulative Distributions, and (c) Tornado Diagrams
of Partial Rank Correlation Coefficients.
Point Prevalence of of Infected sandflies (PIv)
There is a significant difference between the prevalence of infected sandflies for India
(Mean(SD)=0.0372(0.0315)) and Sudan (Mean(SD)=0.0271(0.0143)). There was no
significant difference between the two distributions, (Figure 3.8a - 3.8b, two-sample
Kolmogorov–Smirnov test, p < 0.05). Parameters b, θh, µv, and βvh were most sensi-
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India Sudan
Parameter PRCC(PIh) Rank Parameter PRCC(PIh)
θ −0.9492 1 θ −0.9206
` 0.5646 2 βhv 0.7199
βvh 0.5465 3 b 0.7055
βhv 0.4906 4 βvh 0.6895
b 0.3338* 5 ` 0.5346
µv −0.2700* 6 µv −0.2884
µh 0.1132* 7 µh 0.1247*
φ −0.0075* 8 φ 0.0168*
Table 3.4: A Comparison of the Partial Rank Correlation Coefficients for Input
Parameters of the Output Value (PIh). Where (*) Denotes p < 0.01 for India and
Sudan.
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Figure 3.8: Comparison of Uncertainty and Sensitivity Analysis Results on the
Equilibrium Prevalence of Infected Sandfies (PIv): (a) Frequency Distributions for
Contributions, (b) Empirical Cumulative Distributions, and (c) Tornado Diagrams of
Partial Rank Correlation Coefficients.
tive to the prevalence of infection in sandflies(PIv) for both countries (see Table 3.5
and Figure 3.8c). βhv is more sensitive for India than for Sudan, and b is more sen-
sitive for Sudan than for India. The least important parameters were µh, `, φh, and
βhv.
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India Sudan
Parameter PRCC(PIv) Rank Parameter PRCC(PIv)
θ −0.9562 1 θ −0.9156
βvh 0.8881 2 b 0.9057
b 0.7684 3 βvh 0.8990
µv −0.6930 4 µv −0.5580
µh 0.1664 5 µh 0.2076*
` −0.0277 6 βhv −0.0394*
βhv −0.0096 7 ` −0.0096
φ −0.0093 8 φ −0.0078
Table 3.5: A Comparison of the Partial Rank Correlation Coefficients for Input
Parameters of the Output Value (PIv). Where (*) Denotes p < 0.01. for India and
Sudan.
3.3 Discussion
VL has received much less attention by researchers and policy makers as compared
to many other tropical diseases and, hence, is classified as one of the neglected diseases
by WHO. There are a limited number of studies that collect data to study VL patterns
and even fewer studies that use specific data in a dynamical model for evaluating
control programs. In this research, we carry out an analysis via a thorough literature
review to identify what data is available and what is missing so that we can understand
VL dynamics comprehensively for the two most VL-affected countries (India and
Sudan) in the world.
A dynamic model was then used to capture data-driven VL epidemiological factors
and identify risks associated with frequent VL outbreak. We develop approaches to
estimate model parameters for which data was unavailable and performed parametric
uncertainty and sensitivity analysis on metrics that define risk based on four differ-
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ent definitions. The uncertainty and sensitivity analyses resulted in quantifying the
impact of changes in less precise parameter estimates on the risk for VL, where risk
is measured based on the control reproductive number, prevalences of asymptomatic,
and symptomatic humans, or the prevalence of infectious vectors.
For both countries, we identify similarities and differences in parameter ranking
associated with each of the four definitions of risk for VL. When risk was defined based
on the control reproduction number, the treatment rate was found to be the most
important factor in reducing VL cases in India, whereas in Sudan the transmission
probability from sandfly to human was more important. Many studies have identified
the abundance of P. Orientalis Sandflies in villages with the high density of Acacia
Seyal and Balanites aegyptiaca vegetation, which is assumed to be one of the major
environmental risk factors in Sudan (23; 93; 53; 100). The presence of an infected
individual in these areas increases the likelihood of transmission between human and
sandfly. The presence of domesticated animals also can serve as an attractant for
sandflies in and near homes.
If the risk is defined using the prevalence of asymptomatic VL, the results indicate
that the asymptomatic rate is the most sensitive parameter in both countries. Many
public health researchers recognize that asymptomatic L. Donovani infected individ-
uals as a substantial reservoir of the resurgence of VL infection in the 1970s, following
the Global Malaria Eradication Program in the 1950s and 1960s (19; 10; 35).
One of the most efficient ways to control vector-borne diseases is to identify and
treat infected individuals promptly. Treatment reduces the prevalence of illness in
humans thereby reducing the chance of secondary infection in the vector. Our result
is that the treatment rate, which relates to control, is the most important parameter
in reducing the prevalence in sandflies and humans. Our results support an estab-
lished notion that reducing the prevalence in humans through early identification of
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asymptomatics and prompt treatment integrated with effective vector control can
significantly decrease the prevalence of VL in the sandfly population.
Few modeling studies, on other Neglected tropical diseases, have only evaluated
the role of environmental and socioeconomic risk factors on the transmission dy-
namics of diseases. Black, et al., (16), studied the environmental factors and the
likelihood of transmission for Trypanosoma Cruzi (T. Cruz) seropositivity in two dif-
ferent geographic regions of Ecuador. Within these two regions, there are distinct
insect vector species responsible for the transmission of T. Cruzi. Poorly structured
housing with cracks and holes provided an ideal breeding area for the triatominae
insect (the vector of T. Cruz) (16). A study by Bergquist and Tanner, 2010, (9),
on the burden of Schistosomiasis japonica among the top two countries in the world
(China and the Philippines) found that in China around 5 million individuals are at
risk of Schistosomiasis and 1 million are currently infected, whereas in the Philip-
pines, 560,000 were reported infected in 2008. In India the P. Argentipes is the main
sandfly species responsible for transmission of VL to human populations. During the
1960s, the man-biting rate of sandflies was significantly reduced from DDT spraying
applications that were employed in the malaria eradication campaign and designed
to kill mosquito vectors. This campaign reduced the number of VL cases during this
period (1962-1963), showing no new prorated cases. It was observed that soon af-
ter the DTT spraying campaign stopped the number of VL cases elevated to higher
epidemic levels (4).
High treatment rate is also found to be a critical factor in impacting the dynam-
ics of VL but, primarily in India. However, we assumed effective treatment for all
individuals in the model and did not consider efficacy and toxicity of available drugs.
These assumptions may influence our future findings.
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Chapter 4
ANALYSIS OF VISCERAL LEISHMANIASIS TRANSMISSION DYNAMICS
MODEL
This chapter collects some mathematical details for the VL model. The model
considered here is modified to incorporate disease-induced mortality when treatment
is not made widely available to everyone.
4.0.1 Model Derivation
The Leishmania donovani transmission cycle is anthroponotic and takes place
from human to human via the bite of an infective female Phlebotominae sandfly.
Hence, a compartmental dynamical model for the transmission of VL infection be-
tween the human (host) and sandfly (vector), is considered. The model has five
epidemiological stages: susceptible individuals (Sh), asymptomatic individuals (Ah),
individuals infected with VL (Ih), hospitalized individuals (Th), and individuals who
have recovered and are immune to reinfection (Rh), where Nh = Sh+Ah+Ih+Th+Rh.
Similarly, the sandfly population is assumed to be divided into susceptible sandflies
Sv(t) and infectious sandflies Iv(t), so that Nv = Sv + Iv.
The dynamics of Leishmania donovani transmission in humans and sandflies are
modeled by the system of equations given below:
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Human Population
dSh
dt
= Λh − λvhSh − µhSh
dAh
dt
= λvhSh − (φh + µh)Ah
dIh
dt
= φhAh − (δh1 + θh + µh) Ih
dTh
dt
= θhIh − (γh + δh2 + µh)Th
dRh
dt
= γhTh − µhRh
(4.1)
Sand fly Population
dSv
dt
= Λv − λhvSv − µvSv
dIv
dt
= λhvSv − µvIv
(4.2)
where
λhv = bβhv
Ih
Nh
, (4.3) λvh = bβvh
Iv
Nh
, (4.4)
and Sh1 ≥ Sh2
Parameter Definition Unit Value Source
b Average number of bites per sandfly day−1 0.7997 (45)
βvh Transmission probability when infected sandfly bitessusceptible human Dimensionless 0.0001 Estimated
βhv Transmission probability when susceptible sandfly bites infected humans Dimensionless 0.3 Estimated
δh1 , δh2 Disease-induced death rate for infect humans VL day−1 0.011 (141)
γh Per capita treatment-induced recovery rate from VL infection day−1 0.0016 (142)
Λh Human recruitment rate day−1 0.004 (60)
Λv Sandfly daily recruitment rate day−1 0.0213 (129)
µh Human daily per capita natural mortality rate day−1 4.08e-5 Est. (see App. B)
µv Adult Sand fly daily per capita mortality rate day−1 0.0909 (138)
φh Per capita development rate of clinical symptoms of VL infection day−1 0.0086 (140)
θh Per capita treatment rate of infectious humans day−1 0.0439 (97)
Table 4.1: Parameter Notation, Biological Meaning, Values and Sources.
4.1 Mathematical Analysis
The state variables of the Model (4.1) are non-negative for all time. That is,
all solutions are positively-invariant in the (feasible) parameter and initial condition
regions Ω = Ωh × Ωv ∈ R5+ × R2+ for t ≥ 0.
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4.1.1 Basic Qualitative Features
The basic qualitative properties of System (4.1)–(4.2) are collected in a series of
results.
Theorem 4.1.1. The system (4.1)–(4.2) preserves positivity of solutions. In other
words, the solutions of the model (4.1)–(4.2) with positive initial data remain positive
for all t > 0. Furthermore,
lim sup
t→∞
Nh(t) ≤ Λh
µh
and lim sup
t→∞
Nv(t) ≤ Λv
µv
.
Proof. It is clear from the first equation of the model (4.1)–(4.2) that
dSh
dt
= Λh − λvhSh − µhSh ≥ −(λvh + µh)Sh,
so by a (comparison) theorem from Birkhoff and Rota (see (15)) on differential in-
equality, we get
Sh(t) ≥ Sh(0) exp
{
−
∫ t
0
[λvh(u)]du+ µht
}
> 0.
for each t. This is because Sh(0) > 0, and exponential functions are also positive for
any t. Using a similar approach, it can be shown that all other state variables of the
model remain positive for all t > 0. Furthermore, adding the first five equations of
(4.1), gives:
dNh
dt
= Λh − µhNh − δh1Ih − δh2Th. (4.5)
Thus,
Λh − (µh + δh1 + δh2)Nh(t) ≤
dNh(t)
dt
≤ Λh − µhNh(t)
and
Λh
µh + δh1 + δh2
≤ lim inf
t→∞ Nh(t) ≤ lim supt→∞ Nh(t) ≤
Λh
µh
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so that,
lim sup
t→∞
Nh(t) ≤ Λh
µh
.
Hence, we have that Nh is a bounded solution of system (4.1) and is trapped in the
region
Ωh =
{
(Sh, Ah, Ih, Th, Rh) ∈ R5+ : 0 ≤ Sh + Ah + Ih + Th +Rh ≤
Λ
µ
}
.
Similarly, adding the two equations of model System (4.2)
dNv
dt
= Λv − µvNv.
Let (Sv, Iv) ∈ R2+ be a solution with non-negative initial conditions. Now lim sup
t→∞
Sv =
Λv
µv
. Taking the time derivative along sum the of all solutions curves of system (4.2)
gives
N˙v = Λv −Nhµh
≤ Λv −Nhµh.
By differential inequality theorem (15) we find
0 ≤ Nv (t) ≤ Λvµv +
(
Nv(0)− Λvµv
)
e−µvt,
where Nv (0) represents the initial sandfly population at the initial phase of the disease
process. So as t→∞, the inequality becomes
0 ≤ Nv (t) ≤ Λvµv .
Hence we have that Nv is a bounded solution of System (4.2) and is trapped in the
region
Ωv =
{
(Sv, Iv) ∈ R2+ : 0 ≤ Sv + Iv ≤
Λv
µv
}
.
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Lemma 4.1.2. The following epidemiology feasible region of System (4.1)–(4.2),
defined by Ω = Ωh × Ωv, is positively invariant and attracting.
Proof. It follows from 4.1.1 that dNh(t)
dt
≤ Λh − µhNh(t) and dNv(t)dt = Λv − µvNv(t),
so that dNh
dt
< 0 and dNv
dt
< 0 if Nh(t) > Λhµh and Nv(t) >
Λv
µv
. Thus, by a standard
comparison theorem (15), we find Nh(t) ≤ N(0)e−µht + Λhµh (1− e−µht) and Nv(t) ≤
N(0)e−µvt + Λv
µv
(1− e−µvt). In particular, Nh(t) ≤ Λh/µh and Nv(t) ≤ Λv/µv if
Nh(0) ≤ Λh/µh and Nv(0) ≤ Λv/µv, respectively. Thus, Ω is positively invariant.
Further, if Nh(t) > Λhµh and Nv(t) >
Λv
µv
, then either the solution enters Ω in finite time,
or Nh(t) approaches Λh/µh and Nv(t) approaches Λv/µh, and the infected variables
approach zero. Hence, Ω is attracting (i.e., all solutions in R7+ eventually approach,
enter or stay in Ω).
Hence, the model system (4.1)–(4.2) is epidemiologically and mathematically well-
posed in Ω (71).
4.1.2 Infection-Free Equilibrium and the Basic Reproduction Number
In the rest of this chapter, we will assume for simplicity, that Sh1 = Sh2 . Model (4.1
– 4.2) has the infection-free equilibrium E0 = (Λh/µh, 0, 0, 0, 0,Λv/µv, 0), where the
′ means vector transpose. In order to evaluate the basic reproductive number, we
apply the method shown in (149). We compute the matrices F (for the new infection
terms) and V (for the transition terms):
F =

0 0 bβvhShµvΛv
0 0 0
0 bβhvSvµhΛh 0
 and V =

G1 0 0
−φh G2 0
0 0 µv

. (4.6)
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where G2 modifies to G2 = θh + µh + δh1 The basic reproduction number R0 is the
spectral radius of the matrix FV−1, and
R0 = ρ
(
FV−1
)
=
√
bβhv
µv
· φh(φh + µh) ·
bβvh
(θh + µh + δh1)
· N
∗
h
N∗v
(4.7)
4.1.3 Local Asymptotic Stability of the IFE
Theorem 4.1.3. The disease-free equilibrium point, E0, of model system (4.1- 4.2)
is locally asymptotically stable (LAS) if R0 < 1 and unstable if R0 > 1.
Proof. Linearization at DFE gives
JE0 =

−µh 0 0 0 0 0 −bβvh
0 −G1 0 0 0 0 bβvh
0 φh −G2 0 0 0 0
0 0 θh −G3 0 0 0
0 0 0 γh −µh 0 0
0 0 − bβhvΛvµh
µvΛh 0 0 −µv 0
0 0 bβhvΛvµh
µvΛh 0 0 0 −µv

, (4.8)
where G2 modifies to G2 = θh+µh+δh1 . The characteristic polynomial of the Jacobian
matrix is given by
P (λ) = (λ+ µv) (λ+ µh)2 (λ+G3)
(
λ3 + h2λ2 + h1λ+ h0
)
(4.9)
where h0 = µv (φh + µh) (θh + µh) (1−R20), h1 = (G1 + G2)µv + G1G2 and h2 =
G2 + G1 + µv. We observe that four eigenvalues for this polynomial have negative
real parts, and are given by λ = {−µv,−G3,−µh,−µh} with geometric multiplicity of
two. The remaining expression is a cubic polynomial, P (λ) = λ3 + h2λ2 + h1λ+ h0.
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Applying the Routh-Hurwitz criteria (73), we find the conditions for all eigenvalues to
have negative real parts, that is H1 = h1 > 0, H2 = h0 > 0, and H3 = h2h1 − h0 > 0.
Thus, by Routh-Hurwitz criteria, E0 is locally asymptotically stable for R0 < 1 and
is unstable for R0 > 1.
4.1.4 Existence of Backward Bifurcation
At R0 = 1, the term-free of λ in equation (4.9) vanishes, which implies that the
matrix J0, and therefore JE0 , has a trivial eigenvalue in addition to six more (negative)
eigenvalues. Center manifold analysis near the trivial equilibrium E0 (see Castillo-
Chavez and Song (27)) can be applied here. The approach is based on computing the
two expressions
a1 =
7∑
i,j,k=1
viwjwk
∂2fi
∂xj∂xk
(E0, b0),
b1 =
7∑
i,j=1
viwj
∂2fi
∂xj∂b
(E0, b0)
where x1 = Sh, x2 = Ah, x3 = Ih, x4 = Th, x5 = Rh, x6 = Sv, x7 = Iv and fi(x) =
x˙i, i = 1, 2, , .., 9, is the right hand side of model (4.1–4.2). The parameter b0 represents
the biting rate at R0 = 1, which implies that
b0 =
√
G1G2µvN∗h
φhβhvβvhN∗v
.
The components vi are those of the left eigenvector v of the Jacobian matrix JE0(R0 =
1) and are given by
v1 = v4 = v5 = v6 = 0,
v2 = b0βhvφhµhΛv,
v3 =
G1
φh
v2,
v7 =
G1G2N
∗
h
b0βhvφhN∗v
v2.
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The components wi represent those of the right eigenvector w of the Jacobian matrix
JE0(R0 = 1) and are given by
w1 = −G1
µh
w2,
w2 = b0βvhG2G3µhµvN∗h ,
w3 =
φh
G2
w2,
w4 =
θhφh
G2G3
w2,
w5 =
γhθhφh
G2G3µh
w2,
w6 = −b0φhβhvN
∗
v
G2µvN∗h
w2,
w7 =
G1
b0βvh
w2.
After some calculation, we get
a1 = −2b0
N∗h
(w2 + w3 + w4 + w5)
(
v2w7βvh+ v7w3βhv
N∗v
N∗h
)
+ 2v7w3
b0βhv
N∗h
(
w6 − w1N
∗
v
N∗h
)
= − 2G1v2w
2
2
G2G3µvµhN∗h
{2µv[µhG3(G2 + φh) + φhθh(γh + µh)] +G3(b0φhµhβhv −G1G2µv)},
= − 2G1v2w
2
2
G2G3µvµhN∗h
{2µv[G1G2G3 − φhδh1(G3 + θh)] + b0βhvφhµhG3 −G1G2G3µv}, (4.10)
b1 =
2G1
b0
v2v3 > 0. (4.11)
As the expression b1 is positive, then according to theorem 4.1 of Castillo-Chavez
and Song (27), the model (4.1–4.2) undergoes backward bifurcation at R0 if and only
if the expression a1 is positive, i.e., if
2µv[G1G2G3 − φhδh1(G3 + θh)] + b0βhvφhµhG3 −G1G2G3µv < 0. (4.12)
If δh1 = 0, then the inequality cannot be true. Hence, we have forward bifurcation.
We show the following proposition.
Proposition 4.1.4. Model (4.1–4.2) exhibits backward bifurcation if and only if the
inequality (4.12) holds.
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4.1.5 Endemic Equilibria and Critical Basic Reproduction Number
To find the endemic equilibrium, we set the derivatives in the left hand side of the
model (4.1–4.2) equal to zero and solve the resulting algebraic system, for the case
iv 6= 0 and ih 6= 0 at equilibrium to get the state variables. Thus,
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Figure 4.1: Bifurcation Diagrams for Mean Parameters in India: βvh = 0.0821,
βhv = 0.025, δh1 = 0.011, µh = 4.08 × 10−5, µv = 0.0909, φh = 0.0086, θh = 0.0439,
Λh = 0.0016, Λv = 0.0213, γh = 0.004. Backward Bifurcation: The Solid Curves
(-) Denotes Stable Endemic Equilibrium with Higher Infection Level; The Dashed
Curves (- -) Denote Instable Branch.
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S∗h =
Λh
λvh + µh
,
A∗h =
Λhλvh
G1(λvh + µh)
,
I∗h =
Λhλvhφh
G1G2(λvh + µh)
,
T ∗h =
Λhλvhφhθh
G1G2G3(λvh + µh)
,
R∗h =
Λhγhλvhφhθh
G1G2G3µh(λvh + µh)
,
S∗v =
Λv
λhv + µv
,
I∗v =
Λvλhv
µv(λhv + µv)
.
(4.13)
Now, we substitute equations 4.13 in equations (4.3) and (4.4), to get an equation in
the endemic force of infection λvh as
f(λvh) = A0λ2vh +B0λvh + C0 = 0 (4.14)
where
A0 = µvΛh{G1G2G3 − δh1φh(G3 + θh)}{µv[G1G2G3 − δh1φh(G3 + θh)] + bG3βhvµhφh}
B0 = G1G2G3µh{2µ2vΛh[G1G2G3 − δh1φh(G3 + θh)] + bG3Λhβhvµhµvφh − b2G3Λvβhvβvhµhφh}
C0 = G1G2G23µ2h[G1G2Λhµ2v − Λvβhvβvhµhφhb2].
We notice that the expression
G1G2G3−δh1φh(G3+θh) = (γh+δh1+µh)[φh(θh+µh)+µh(θh+δh1+µh)]−δh1φhθh > 0.
Because all model parameters are strictly positive, except δh1 representing the Vis-
ceral Leishmaniasis disease-induced mortality rate, then the expression A0 is positive.
However, both B0 and C0 can be positive or negative, depending on parameter values.
This implies that Equation (4.14) may have up to two feasible solutions (a solution
that satisfies λvh ∈ [0,∞)). It is clear that C0 < 0 corresponds to R0 > 1, while
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C0 > 0 corresponds to R0 < 1. If R0 > 1, then there are two solutions of equation
(4.14), of which only one is feasible (positive) while the other is not feasible. This
solution is given by
λ+hv =
−B0 +
√
B20 − 4A0C0
2A0
. (4.15)
However, if R0 = 1, then C0 = 0 and therefore a positive solution of (4.14) exists only
if B0 < 0. This solution is given by −B0/A0. If R0 < 1 then C0 > 0, and therefore
positive solutions of (4.14) exist only if B0 < 0 and B20 − 4A0C0 > 0, while otherwise
no feasible solutions exists. One of the two feasible solutions is given by (4.15) while
the other is given by
λ−hv =
−B0 −
√
B20 − 4A0C0
2A0
. (4.16)
Hence, in addition to the infection-free equilibrium, if:
• C0 < 0, then a unique endemic equilibrium exists and corresponds to a value of
the endemic force of infection λhv given by (4.15).
• C0 = 0, then an endemic equilibrium exists only if B0 < 0 and corresponds to
the solution given by (4.15).
• C0 > 0, B0 < 0 and B20 − 4A0C0 ≥ 0, then two endemic equilibria exist and
correspond to the two feasible solutions of equation (4.14) which are given by
(4.15) and (4.16).
• otherwise, no endemic equilibrium exists.
The conditions in the third bullet are of great interest, as they show the possible exis-
tence of backward bifurcation for values of R0 < 1. To find the backward bifurcation
range, in terms of R0, we set the discriminant B20 − 4A0C0 equal to zero and solve for
the critical value of R0 (which we call R?0), where
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R?0 =
√
φh(Q1 + 2
√
Q2)
Q3
, (4.17)
Q1 = βhvΛhµh[2δh1φh(G3 + θh)−G1G2G3],
Q2 = βhvΛhµhδh1(G3 + θh)(G1G2Λvβvh − Λhµhφhβhv)(G1G2G3 − δh1φh(G3 + θh)),
Q3 = G1G2G3
√
βhvβvhG1G2µhΛhΛv.
Thus, two endemic equilibria exist for values of R?0 < R0 < 1. This phenomenon
is known as backward bifurcation (121; 122; 75; 47) (ee bifurcation diagram in Fig
4.1). Simulations are done for parameter values as estimated in Table 4.1, except δh1 ,
which has been chosen to be δh1 = 0.011 day−1.
0.7 0.8 0.9 1 1.1
0
1
2
3
4
5
6
x 10−4
R0
λ
h
v
δ =0.0033
δ =0.0056
δ =0.0078
δ =0.01
δ =0.012
Figure 4.2: Changes in the Qualitative Behavior of the Model Under Effective Treat-
ment. Observe that the Bifurcation Diagram in Figure 4.1 Collapses to a Forward
Bifurcation as Disease Mortality (δh1) Decrease as a Result of Perfect Treating of
Humans.
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4.2 Conclusion
In this Chapter, we studied and analyzed a vector-borne model and showed the
existence of multiple endemic equilibria when the basic reproduction number is less
than one. Under perfect treatment, there exists (unique) disease-free and an endemic
equilibria. The dynamical scenarios shown via the model analysis, have also been
observed in VL prevalence trends for some countries. For example, extensive DDT
insecticide spraying in India in 2007 (91) resulted in the elimination of VL from
some districts in India, whereas in some other district, VL came back after few years
without any local cases and became endemic. These two distinct scenarios might
be because of varying migration patterns, i.e., different levels of influx of infected
individuals in the two types of districts.
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Chapter 5
DISCUSSION AND LIMITATIONS
In this dissertation, we have investigated the role of regional risk factors on the
transmission dynamics of Visceral Leishmaniasis (VL) via novel mathematical esti-
mation methods in the face of limited data. The study has contributed significantly,
via development and implementation of model parameterization procedure, to the
field of mathematical epidemiology for vector-borne infectious diseases. We showed
how to collect and compile consistent data from the literature, to estimate model
parameters using such data, and to use parameter estimates to assess dynamics of
VL.
The literature is reviewed thoroughly to gather relevant data for the model in
Chapter 2. The review of the literature resulted in two distinct sets of data for
estimating the model parameters. However, an attempt to find data on transmission
probabilities was not successful, and, hence, a two model based novel estimation
procedures were developed in the study. The first procedure makes use of the data on
the VL prevalence in humans and sandflies, whereas the second estimation method
uses the estimates of the control reproduction number. Having obtained estimates of
model parameters, the risks associated with VL for the two data sets were assessed.
The risk of VL was evaluated based on the four different output metrics (reproduction
number, the prevalence of asymptomatic human hosts, the prevalence of symptomatic
infectious humans, and the prevalence of infected sandflies) obtained from the model
analysis.
Using the methodology developed in Chapter 2, a comparative VL risk analysis is
performed in Chapter 3 for the two highly VL-endemic countries in the world: India
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and Sudan. A comparative assessment was conducted to identify differences in risk
factors associated with VL. From the analysis, we concluded that there are varying
risks factors (environmental, ecological and socio-economic) for VL and the sensitivity
of these factors depends on the structures of the community.
In Chapter 4, we provided some mathematical details of the model (2.1)–(2.2).
The analytical results suggest derivation of the two threshold expression (Rc and
R∗c), estimates of which led to either disease extinction or disease persistence. The
parameter space is divided into three regions with distinct dynamics: (i) disease
extinction is the only possibility if 0 ≤ Rc < R∗c , (ii) disease persistence at an endemic
level is the only possibility when 1 ≤ Rc, and (iii) disease extinction or persistence
both can happen in the long run but the eventual state depends on the initial size of
the infectious individuals in the population if R∗c ≤ Rc < 1. This type of qualitative
behavior in the literature is referred to as backward bifurcation. Furthermore, if
treatment rate is assumed to be zero in the model, then the region (iii) vanishes,
resulting in a typical forward bifurcation scenario as shown by numerous studies in
the literature (75; 30; 121; 122).
Limitation: Throughout the development of this study, we encountered several chal-
lenges. Initially, in an attempt to gather parameter estimates for the respective
countries from field data, we found that much of the data in the literature is either
outdated or from different time periods. For example, the human landing collection is
considered unethical, because study worker/participant in VL-endemic areas may be
at risk of being bitten by an infected sandfly during the data collection process (135).
Many of the empirical studies, were conducted in the 1980s and 1990s, during which
only limited development had taken place to reduce the exposure of sandflies through
vector control and effective treatment. To get a measure of the human landing catch
of sandflies, field scientists now rely on new and novel methods including indoor Cen-
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ters for Disease Control (CDC) light trap, sticky oil traps, rodent-baited traps, and
human bait catches (90; 59; 44). Second, this study made use of many empirical stud-
ies conducted in varying geographic locations where data may have originated and
employed different technics of data collection. Compiling these estimates together
may introduce uncertainties in parameter estimates when paired in a model. The
prevalence of VL was approximated using estimates for a per-population sample size
of 10000 and was then used to estimate the prevalence for the entire population.
Future Work: In my future work, I would like to consider all six major VL-affected
geographic regions (India, Bangladesh, Sudan, South Sudan, Brazil, and Ethiopia)
and perform the comparative analysis between them to identify the risk factors in each
of the countries. The implications for such studies would provide health organizations
with a globally coordinated perspective on VL and help with the design of better
control or eradication programs. Additionally, I will modify the model to include
more disease compartments to allow different types of field diagnostic methods used
in the various countries as well as reservoir hosts. The study will eventually increase
our understanding of the role of disease complication when partially treated recovery
individuals develop a complication.
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APPENDIX A
MODEL DERIVATION AND COMPUTATIONS
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A.1 Complete Model Derivation
The dynamics of Leishmania donovani transmission in humans and sandflies are
modeled by the system of equations given by model (2.1)–(2.2) in wich the force
of infection is modeled by Equation B.0.1. Newly infected but not yet infectious
individuals move into the asymptomatic population (sub-clinical infection, exposed
to VL but not yet infectious), who may exit the system through natural death or
through progress to clinical VL. The change in Ah population is
dAh
dt
= λvhSh − (φh + µh)Ah.
The asymptomatic can then progress to a VL clinical symptoms stage (Ih) at the rate
φh:
dIh
dt
= φhAh − (µh + θh) Ih,
where θh is the per-capita treatment rate and µh is the per-capita departure rate.
The infectious individuals with clinical symptoms may enter treatment (Th) at the
rate θh. Through successful treatment, individuals recover at the rate γh, and hence
dTh
dt
= θhIh − (γh + µh)Th.
The population of recovered individuals from VL (Rh) is increased following successful
treatment, leading to permanent immunity into the Rh class (at the rate γh). The
population is decreased by natural death and is given by
dRh
dt
= γhTh − µhRh.
The population of new female sandflies (Sv) is increased by an adult recruitment rate
(λv) and decrease by natural mortality (µv). The vector in this population can acquire
the L. Donovani parasite from an infectious human at a rate λv and is modeled by
Equation 2.4. The change in the susceptible population is described by
dSv
dt
= Λv − λhvSv − µvSv.
The population of infected female sandflies is generated at the per-capita rate λhv
and diminished by the natural death rate µv. Thus,
dIv
dt
= λhvSv − µv.
A.2 Details of the Analytical Results of VL Model
A.2.1 Derivation of the Basic Reproductive Number
For simplification, we let G1 = φh+µh, G2 = θh+µh and G3 = γ+µh. Considering
the infected sub-populations Ih(t), Ah(t), and Iv(t), we let F be the rate of new
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infections into the infected compartments and V be the rate of exit of humans into
infected compartments:
d
dt
 AhIh
Iv
 = F − V =

bmv:hβvhIvSh
Nv
0
bβhvIhSv
Nh
−
 (φh + µh)Ah−φhAh + (θh + µh) Ih
µvIv
 . (A.1)
We apply the next generation operator method presented in (149), where F is con-
sidered to be the vector of rates of inflow of new infections in each compartment
and V = V+ + V− is the vector of rates transfer rates of individuals into and out
of the infective compartments by all other processes. Taking the Jacobian ma-
trix of each vector with respect to each of the infectious classes and evaluating at
E0 = (Λh/µh, 0, 0, 0, 0,Λv/µv, 0) gives
F =
 0 0 bmv:hβvh0 0 0
0 bβhvΛvµhΛhµv 0
 and V =

G1 0 0
−φh G2 0
0 0 µv
 . (A.2)
Computing FV−1, we obtain
FV−1 =

0 0 bmv:hβvh
µv
0 0 0
bβhvΛvµhφh
µvΛhG1G2
bβhvΛvµh
µvΛhG2 0
 . (A.3)
Taking the spectral radius of the next generation matrix operator, ρ
(
FV−1
)
, gives
RC = ρ
(
FV−1
)
=
√
bβhv
µv
· bβvhφh(φh + µh) (θh + µh) ·mv:h.
(A.4)
A.2.2 Positivity and Boundedness of Solutions
Since this model is of epidemiologyical relevance, all its associated parameters are
non-negative. Further, the following non-negativity result holds. The state variables
of the model (2.1) are non-negative for all time, so solutions are positively invariant
in Ω = Ωh × Ωv, where
Ωh =
{
(Sh, Ah, Ih, Th, Rh) ∈ R5+ : Sh + Ah + Ih + Th +Rh ≤
Λh
µh
}
,
Ωv =
{
(Sv, Iv) ∈ R2+ : Sv + Iv ≤
Λv
µv
}
.
Remark A.2.1. If all initial conditions start in region Ω = Ωh × Ωv, then all corre-
sponding solutions (Sh, Ah, Ih, Th, Rh, Sv, Iv)′ are non-negative for all t > 0, where ′
means vector transpose.
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Proof. Because this model is of epidemiological relevance, we first show that the region
Ω is positively invariant in R7+, with respect to the system (1) and (2). It is easy to
see that S˙h |Sh=0> 0, A˙h |Ah=0> 0, I˙h |Ih=0> 0, T˙h |Th=0> 0, R˙h |Rh=0> 0, S˙v |Sv=0>
0, I˙v |IV =0> 0. Hence, all trajectories point to inside the region Ω (where the dot
means derivative with respect to time). Also, the time derivative along all solutions
of (1) is
dNh
dt
= Λh −Nhµh
≤ Λh −Nhµh.
It is clear that dNh/dt < 0 if Nh > Λh/µh. Hence, on applying a (comparison)
theorem from Birkhoff and Rota ((15)) on differential inequality, we get
0 ≤ Nh (t) ≤ Λh
µh
+
(
Nh(0)− Λh
µh
)
e−µht.
When t → ∞, then Nh < Λh/µh. Thus, for initial conditions Nh(0) < Λh/µh, we
have Nh(t) < Λh/µh. Similarly, let (Sv, Iv) ∈ R2+ be the solution with non-negative
initial solution. Taking the time derivative along the sum of all solutions curves of
model (2) gives
Nv
dt
= Λv −Nhµh
≤ Λv −Nhµh.
By differential inequality theorem in (15), we find
0 ≤ Nv (t) ≤ Λv
µv
+
(
Nv(0)− Λv
µv
)
e−µvt,
where Nv (0) represents the initial sandfly population at the initial phase of the dis-
ease. As t→∞, the inequality becomes
0 ≤ lim
t→∞Nv (t) ≤
Λv
µv
.
In particular, we have Nv(t) < Λv/µv if Nv(0) < Λv/µv. Hence the region Ω is
positively invariant. Furthermore, if we start with initial conditions Nh(0) > Λh/µh
and Nv(0) > Λv/µv, then either the solutions enter Ω in finite time or Nh(t)→ Λh/µh
and Nv(t)→ Λv/µv, as t→∞.
Hence, for the model (2.1–2.2), the compact set Ω is a positively invariant and
absorbing set that attracts all solutions of model (2.1–2.2) starting in R7+.
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A.2.3 Stability Analysis of the Disease-Free Equilibrium Point (DFE)
Local stability of the Endemic Equilibrium (DFE)
Remark A.2.2. The disease-free equilibrium point, E0, of model system 2.1- 2.2 is
locally asymptotically stable (LAS) if RC < 1, and unstable if RC > 1.
Proof. Linearization at DFE gives
J(E0) =

−µh 0 0 0 0 0 −bβvh
0 −G1 0 0 0 0 bβvh
0 φh −G2 0 0 0 0
0 0 θh −G3 0 0 0
0 0 0 γh −µh 0 0
0 0 − bβhvΛvµh
µvΛh 0 0 −µv 0
0 0 bβhvΛvµh
µvΛh 0 0 0 −µv

(A.5)
The characteristic polynomial of the Jacobian matrix J(E0) is given by
P (λ) = (λ+ µv) (λ+ µh)2 (λ+G3)
(
λ3 + h2λ2 + h1λ+ h0
)
(A.6)
where h0 = µv (φh + µh) (θh + µh) (1−R2C), h1 = (G1 + G2)µv + G1G2 and h2 =
G2 + G1 + µv. We observe that four eigenvalues for this polynomial have negative
real parts, and are given by λ = {−µv,−G3,−µh,−µh} with geometric multiplicity of
two. The remaining expression is a cubic polynomial, P (λ) = λ3 + h2λ2 + h1λ+ h0.
Applying the Routh-Hurwitz criteria (73), we find the conditions for all eigenvalues to
have negative real parts, that is H1 = h1 > 0, H2 = h0 > 0, and H3 = h2h1 − h0 > 0.
Thus by Routh-Hurwitz criteria, E0 is locally asymptotically stable for RC < 1 and
is unstable for RC > 1.
Global Stability of the Disease-free Equilibrium (DFE)
Remark A.2.3. The disease-free equilibrium E0 =
(
Λh
µh
, 0, 0, 0, 0, Λv
µv
, 0
)
of model sys-
tem 2.1- 2.2 is globally asymptotically stable in Ω whenever RC < 1 and unstable if
RC > 1.
Proof. Consider a candidate Lyapunov function defined in Ω,
L (t) =L1
(
Sh − S∗h − S∗h log
(
Sh
S∗h
))
+ L2Ah + L3Ih
+ L4
(
Sv − S∗v − S∗v log
(
Sv
S∗v
))
+ L5Iv
(A.7)
where the constants Li, i = 1...5 are taken to be L1 = L2 = µhR2C , L3 = L3φ , and
L4 = L5 = µvR
2
C
bβvh
. The function L is positive definite, in the sense that it vanishes
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only at the disease-free equilibrium while otherwise it is positive in Ω. Moreover,
taking the time derivative of the function in (A.7) along solutions of system 2.1–2.2
and then substituting the expression for the derivatives, gives
˙L =L1
(
1− S
∗
h
Sh
)(
Λv − bβvhIvSh
N∗h
− µhSv
)
+ L2
(
bβvhIvSh
N∗h
−G1Ah
)
+ L3 (φAh −G2Ih)
+ L4
(
1− S
∗
v
Sv
)(
Λv − bβhvSvIh
N∗h
− µvSv
)
+ L5
(
bβhvSvIh
N∗h
− µvIv
) (A.8)
Substituting the Li constants in equation A.8 and then grouping and collecting
terms, gives
L˙ = µhR2C
(
2− Sh
S∗h
− S
∗
h
Sh
)
+ µvR
2
C
bβvh
(
2− Sv
S∗v
− S
∗
v
Sv
)
+
(R20 − 1) µvφ (G1R2CG2Kh + bβvhKvφ) .
(A.9)
The first two terms are negative, as the arithmetic mean is greater than or equal
to the geometrical mean. However, the third term is negative for values of R0 < 1.
Therefore, by Lyapunov-LaSalle asymptotic stability (88), the disease-free equilibrium
E0 is globally asymptotically stable if R0 < 1 for all t > 0.
A.2.4 Stability Analysis of the Endemic Equilibrium Point, E∗
As a result of no disease deaths, observeD in Figure 4.2, the existence of a DFE
and an Endemic Equilibrium (EE) that depends on RC . In this section, we show the
local and global stability of the EE when R∗C become 1.
Local Stability of the Endemic Equilibrium (EE)
Remark A.2.4. If RC > 1, then the unique positive endemic equilibrium(EE), E∗, for
Model system equations 2.1–2.2 is locally asymptotically stable.
Proof. The EE of the Model system equations 2.1–2.2 is given by Eˆ*. The Jcobian
matrix at EE gives by
J(E∗) =

−bβvhI∗v − µh 0 0 0 0 0 −bβvhS∗
bβvhI
∗
v −G1 0 0 0 0 bβvhS∗
0 φh −G3 0 0 0 0
0 0 θh −G3 0 0 0
0 0 0 γh −µh 0 0
0 0 −bβhvS∗v 0 0 −bβhvI∗h − µv 0
0 0 bβhvS∗v 0 0 bβhvbβhvI∗h −µv

.
It’s characteristic polynomial is given by
P (λ) = (λ+ µh) (λ+G3) (µv + λ)
(
λ4 + h3λ3 + h2λ2 + h1λ+ h0
)
,
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where
h3 =bβvhI∗v + bβhvI∗h +G2 +G1 + µv + µh,
h2 =b2βhvI∗hβvhI∗v + bβhvI∗hµh + µvbβvhI∗v +G2bβvhI∗v + bβhvI∗hG2
+G1bβvhI∗v + bβhvI∗hG1 +G1µh + µvµh +G2µh + µvG2 + µvG1 +G2G1,
h1 =
φh,βhvb(βvhµhβhvφh (G1+G2)b2+((G2+µv)G1+µvG2)G1G2βvhb+µhG22G12)µh
G1(G2G1µv+µhbβhvφh)G2
+ G1G2µvµh (R
2
C − 1)
bβvh + µh
,
h0 =µvµhG1G2
(
R2C − 1
)
.
We observe that the characteristic polynomial P (λ) can be factored to roots λ =
−µh,−µv,−G3 and P (λ) = (λ4 + h3λ3 + h2λ2 + h1λ+ h0). Applying the Routh-
Hurwitz conditions: hi > 0, (i = 0, ..., 4), h1h2 − h0h3 > 0, and h1h2h3 > h1 + h0h23,
we find that
h1h2 − h0h3 = IhIvβvhβhv (Ihβhv+Ivβvh) b3 +
(
(Ihβhv+Ivβvh)2G1 +(Ihβhv+Ivβvh)2G2
+ Iv2µvβvh2 + 2 IhIvβhv (µh + µv) βvh + Ih2µhβhv2
)
b2
+
(
(Ihβhv + Ivβvh)G12 + 2 (Ihβhv + Ivβvh) (G2 + µh + µv)G1
+ (Ihβhv + Ivβvh)G22 + 2 (µh + µv) (Ihβhv + Ivβvh)G2
+ 2 Iv (µh + 1/2µv)µvβvh + Ihµhβhv (µh + 2µv)
)
a
+ ((G2 + µh + µv)G1 + (µh + µv) (G2 + µh)) (G1 +G2 + µv)
> 0
(A.10)
and
h1h2h3 − h21 + h0h23 =
(
βhvIhIvβvh (G1 +G2) b2
+ (((Ihβhv + Ivβvh)G2 + µhβhvIh + µvβvhIv)G1
+G2 (µhβhvIh + µvβvhIv)) a
+ µh ((G2 + µv)G1 + µvG2)
) ((
b2IhIvβvhβhv
+((Ihβhv+Ivβvh)G1+(Ihβhv+Ivβvh)G2+µhβhvIh+µvβvhIv) a
+ (G2 + µh + µv)G1 + (µh + µv)G2 + µhµv
)
(b (Ihβhv + Ivβvh)
+G1 +G2 + µh + µv)− βhvIhIvβvh (G1 +G2) b2
− (((Ihβhv + Ivβvh)G2 + µhβhvIh + µvβvhIv)G1
+G2 (µhβhvIh + µvβvhIv)) a− µh ((G2 + µv)G1 + µvG2)
)
− (b (Ihβhv + Ivβh) +G1 +G2 + µh + µv)2 bG1G2 (aIhIvβvhβhv
+ µhβvIh + µvβvhIv)
> 0
(A.11)
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hold when RC > 1. Thus, the endemic equilibrium, E∗, is locally asymptotically
stable because all eigenvalues of the septic polynomial have all negative real parts for
RC > 1.
Global stability of the Endemic Equilibrium (EE)
Remark A.2.5. If RC > 1, then the unique positive endemic equilibrium, E∗, for
Model (2.1–2.2) is globally asymptotically stable.
Proof. Consider a candidate Lyapunov function defined in Ω,
L (t) = L1
[
Sh − S∗h − S∗h log
(
Sh
S∗h
)]
+ L2
[
Ah − A∗h − A∗h log
(
Ah
A∗h
)]
+ L3
[
Ih − I∗h − I∗h log
(
Ih
I∗h
)]
+ L4
[
Sv − S∗v − S∗v log
(
Sv
S∗v
)]
+ L5
[
Iv − I∗v − I∗v log
(
Iv
I∗v
)]
,
(A.12)
where the constants Li, i = 1...5 are given by L1 = L2 = N
∗
h
bβvhI∗vS∗h
, L3 = 1φhA∗h ,
and L4 = L5 = N
∗
h
bβhvS∗vI∗h
. Taking the time derivative of the Lyapunov function in
(A.12) along solutions of system 2.1–2.2 and then substituting the expression for the
derivatives gives
L˙ = L1
(
1− S
∗
h
Sh
)(
Λh − bβvhIvSh
N∗h
− µhSv
)
+ L2
(
1− A
∗
h
Ah
)(
bβvhIvSh
N∗h
−G1Ah
)
+ L3
(
1− I
∗
h
Ih
)
(φhAh −G2Ih) + L4
(
1− S
∗
v
Sv
)(
Λv − bβhvSvIh
N∗h
− µvSv
)
+ L5
(
1− I
∗
v
Iv
)(
bβhvSvIh
N∗h
− µvIv
)
.
(A.13)
Substituting the Li in A.13 and performing some algebra gives
L˙ = µhN
∗
h
bβvhI∗vS
∗
h
(
2− Sh
S∗h
− S
∗
h
Sh
)
+ µhN
∗
h
bβhvS∗vI
∗
h
(
2− Sv
S∗v
− S
∗
v
Sv
)
+ 5− S
∗
v
Sv
− I
∗
vSvIh
S∗vI
∗
hIv
− S
∗
h
Sh
− A
∗
hIvSh
I∗vS
∗
hAh
− I
∗
hAh
A∗hIh
(A.14)
The first two terms in parenthesis and the remaining expression are negative, as
the arithmetic mean is greater than or equal to the geometrical mean. Therefore,
by LaSalle’s Invariable Principle (88), the endemic equilibrium point E∗ is globally
asymptotically stable in Ω for R0 > 1 for all t > 0.
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APPENDIX B
ESTIMATING MODEL PARAMETERS
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B.0.1 Estimating Model Parameters
After extensive searching of the literature, annual reports, and census data, eco-
logical and epidemiological parameter ranges for the respective human and sandfly
populations in India and Sudan were gathered and estimated. See Table 2.2 for a
summary of these estimates.
b: The per-capita daily biting rate on humans by female Phlebotomus sandflies
species differ by geographical region.
P. Argentipes (India): On average, the biting rate of a sandfly on a human
per night was estimated to be 0.85 per day and range from 0.2 to 2.5 per
day (87). More current studies found a mean estimates biting density per
day to be 0.7997 with a range of 0.1667 to 2.0833 per day (45). From these
studies, we calculated the mean number of bites on a human to be 0.7997
with a range of 0.1667 to 2.083 bites per human.
P. Orientalis (Sudan): In a field investigations conducted by Elnaiem, et al.,
the average bites per man-night was estimated to range from 23.7 to 40.3
for no bed net and 4.2 to 9.6 for those using untreated bed nets over a
period of 12 nights (54). In both studies, an average of 32 bites per man-
night was established over a period of 12 nights. In our model we took
the average biting rate to be 1.6208 per man-night with a range of 0.35 to
3.3583 per man-night.
βhv: The transmission probability that an uninfected sandfly acquires a VL parasite
from an infectious human.
India Parameter estimates were taken from a recent modeling study on VL
in India by Stauch A, et al.(138; 139). From these, we took the mean
transmission potential to be 0.025 with a range between 0.013 and 0.063.
Sudan We use the infection rate for sandflies, using an equation from our model
to estimate βhv. We first solve for βhv in this expression and use average
infection rates of 9.6% (126), 8.6% (69) and 6.9%, and 3.6% (57) and the
average biting rates in Table 2.2. The average transmission potential in
human for P. Orientalis was estimated to be 0.1275 with a range of 0.0640
to 0.1706.
βvh: The transmission probability, is the probability that a VL-infectious sandfly
transmits to a human.
India Parameter estimates were generated by solving for βvh in our RC ex-
pression
βvh =
R2Cµv (µh + θ) (φ+ µh)
βhvφb2mV :h
(B.1)
and then pairing samples of known values in Table 2.2 together with an
estimated RC value of 2.01 by Mubayi, et al. (2010(97)). From this
calculation, the mean transmission coefficients were estimated as 0.0694
with a range of 0.0266–0.1652.
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Sudan A similar approach from India was taken and applied to Sudan using
know parameter estimates from Table 2.2 and an estimated RC value of
1.3 from ELmojtaba, et al, 2010 (52). The calculations yield an average
estimate for βvh as 0.0012 with a range of 0.0007–0.0020.
µv: The per-capita daily mortality rate of an adult sandfly, taken as 1/ (life ex-
pectancy of sandflies)
P. Argentipes (India) The mortality for this species of sandfly varies be-
tween 0.125 to 0.1 (128) and 0.0667 to 0.1 (109) per day. Some studies
established the average lifespan to be, 0.0833 per day (74; 84) and 0.091
per day (138). For this species, the per-capita mortality rate was averaged
out from these studies to be µv = 0.0833 per day with a range of 0.0667
to 0.1 per day.
P. Orientalis (Sudan) The adult life span of this species has not been well
studied. In one extensive study, the whole life cycle range was 48–60
days (68). From this study, the combine time of the four (4) different
developmental larval stages and the pupation stage gives a range of 40 to
56 days. So, the life span of adult sandflies ranges from 10 to 14 days
and average 12 days. For this species, the per-capita mortality rate was
averaged out to be, µv = 0.0857 per day and ranges from 0.1 to 0.0714 per
day.
`: The human landing rate of an adult female sandflies was used as a approximate
measure of the human biting rate. Before the late 1990s, the human landing
catches (HLC), was a common way for measuring the human landing rate of
Phlebotomine sandflies. However, for ethical reasons, this method is less com-
monly used and has been replaced with the use of human baits and Centers for
Disease Control light traps (CDCLT) to attract female sandflies. In a compari-
son study, Dilger, E. (2013) investigated the relationship between the number of
sandflies caught by HLC and CDCLT upon humans and showed that CDCLT
are appropriate for estimating the number of sandflies visiting humans (43).
Various comparatives on HLC and CDCLT were used as measured to establish
an appropriate parameter range for the human landing rate.
P. Argentipes (India) In this study conducted by Joshi B, et al. (2009) (77)
on the collection of P. Argentines per house per night using CDC LT, we
took the mean number of landing 12.15 with a range of 8.68 to17.
P. Orientalis (Sudan) From a studies conducted on the effectiveness of im-
pregnated bed net on the landing/bite of female P. Orientalis human vol-
unteers by Elnaiem et al. (1999, 2011), we took the mean number of human
landing rate to be 32 landing/human/per day with a range 15.7 to 48.3
landing/human/per day (54; 59).
µh: For both India and Sudan, the average life expectancy at birth in a year was
collected from multiple censored data sources. Using these sources, we estimate
the per-person/day natural death rate as (average life expectancy ×365)−1. For
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each of these respective regions, the mean and range of the natural death rates
was estimated to be:
India From the mean data from multiple survey sites, we found the per-capita
natural death rate to be 4.55e-5 (Census of India, 2001), 4.28e-5 (hetv.org,
2012), 4.08e-5 (cia.gov, 2010), 4.33e-5 (WHO, 2012), and 4.27e-5 (un.org,
2012). Combining the estimates of these various value gave a mean death
rate of per human/day and range of 4.05e-5 to 5.03e-5 per human/day.
Sudan Similarly from India, the per-capita natural death rate was found to be
4.55e-5 (Coutinho, 2005), 4.38e − 5 (cia.gov, 2012), 4.49e − 5 (unicef.org,
2012), 4.09e − 5 (WHO, 2012) and 4.54e-5 (un.org, 2012). The mean
death rate of 4.3e− 5 per human/day and range of 4.e− 5 to 4.54e− 5 per
human/day.
φ : The per-capita rate of progression of humans from the asymptomatic state to the
infectious state here is taken at incubation of VL before becoming symptomatic.
The incubating period is known to vary from weeks to years among different
individuals.
India The day−1 asymptomatic rate has been estimated to be 0.0086 (day−1)
(140), 0.0055 (147; 103) and range between 0.0055−−0.0164 (day−1) (29)
and 0.0167 to 0.0083 (day−1) (105). We consider these estimates and took
the asymptomatic rate incubating period, φ, to be 0.00975 (day−1) with a
range of 0.006–0.0167 (day−1).
Sudan For this region, the day−1 asymptomatic rates ranges were estimated
to be 0.0083 to 0.01667 (day−1) (62), 0.0055 to 0.0164 (day−1) (22; 29),
and specific mean rates are give in 0.0167 (day−1) with a rang of 0.0111
to 0.0042 (day−1) (65). The asymptomatic rate incubating period, taken
as an average of all these studies was taken to be φ = 0.0098 (day−1) and
range from 0.0042 to 0.0167 (day−1).
θ: Treatment rate from VL here is defined as the mean duration of illness before
seeking treatment in some treatment fertility.
India Current estimates for treatment were found to be 1.996 (who2007), 4
months (0.5–19 months) (1), 4 months (12), and 3.5 (13). From these
study we took the mean estimated treatment rate per day was θ = 0.0351
(day−1) with a range of 0.0067 to 0.0597 (day−1).
Sudan The estimated mean rates per person/day varied from 0.0164 (31; 100),
0.0130, 0.0055 (3), 0.0108 (0.0027–0.0408) (78), (0.0033–0.0235) (95) and
a range of 0.0111–0.0056 in (127). We took the mean estimate for θ as
0.014275 (day−1) with a range of 0.0027 to 0.0408 (day−1).
Λh: The per-capita recruitment rates is defined as the sum per-capita birth rate and
per-capita net migration rate of the population.
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India To estimate the per-capita recruitment rate, we use demographic data
on population size, birth rate, and migration from CIA World Factbook.
The average estimated recruitment rate was calculated as the sum of the
birth rate and net immigration per day and is given by 8.3e-5 persons per
day, ranging from 7.67e-5 to 9.22e-5 persons per day.
Sudan Similar to the estimation for India, the average estimated recruitment
was 1.27e-4 persons per day, with a range of 1.1e-4 to 1.35e-4 persons per
day.
Λv: The per-capita daily adult sandfly recruitment rate of female phlebotomus sand-
fly. Seasonality plays a role in the abundance of the sandfly population in each
geographical region. Few studies have established an average recruitment rate
for sandflies to 0.02128 × Nh per day (128) and 0.299 per day (79). For our
model, we consider the recruitment rate for both species to be Λv = 0.1601 per
day and range from 0.0213 to 0.299 per day.
PIh: Prevalence for VL in humans is defined as the proportion of people with the
disease at a given point in time.
India To estimate the per day prevalence, a study based on Serodiagnostic
Test in Madhepura District of Bihar, India, was considered by Srivastava
N, et al., 2014 (136). From this study, we use the annual prevalence per
10000 of 26.92 in 2010 and 23.78 in 2011 together with the total population
of Madhepura assumed to be at risk to estimate the per person per day
prevalence. The prevalence range was estimated to be between 0.0013 to
0.0015 persons per day.
Sudan A Survey study by Khalil et al. 2000 (81), gave the prevalence of active
disease a range from 40 to 80 per 1000. Using these estimates, together
with reported estimates of the at risk population in Pigott et al., 2014
(114), a rough estimate of the daily prevalence range of 0.0006 to 0.0013
persons per was generated for Sudan’s population.
PIv : Prevalence for VL in sandflies is defined as the proportion of sandflies with VL
at a given point in time.
Point Prevalence of sandflies
Species Min Max Mean Reference
P. argentipes 0.0085 0.0284 - (146)
0.005 0.05 - (98)
0.007 0.02 - (108; 119; 124; 144)
P. orientalis 0.019 0.05 - (59)
0.0054 0.037 0.0157 (70)
0.035 0.071 - (57)
Table B.1: Point Prevalence Estimates for VL in India and Sudan for Host and
Vector From Various Sample-Based Field Studies.
RC: Estimated ranges for both countries were taken from previous mathematical and
modeling studies.
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India RCI was estimated to 2.0± 0.25 (138; 97)
Sudan RCS was estimated to be 1.3± 0.25 (52)
India
Year µv µh Nh Λh = µhNh Nv = mv:hNh Λv = µvNv
2000 0.0833 4.41e-5 1042261758 45937 5492719465 392337105
2001 0.0833 4.38e-5 1059500888 46402 5583569680 398826406
2002 0.0833 4.35e-5 1076705723 46861 5674239160 405302797
2003 0.0833 4.33e-5 1093786762 47311 5764256236 411732588
2004 0.0833 4.30e-5 1110626108 47750 5852999589 418071399
2005 0.0833 4.27e-5 1127143548 48178 5940046498 424289036
2006 0.0833 4.25e-5 1143289350 48597 6025134875 430366777
2007 0.0833 4.23e-5 1159095250 49011 6108431968 436316569
2008 0.0833 4.21e-5 1174662334 49425 6190470500 442176464
2009 0.0833 4.19e-5 1190138069 49847 6272027624 448001973
2010 0.0833 4.17e-5 1205624648 50280 6353641895 453831564
2011 0.0833 4.15e-5 1221156319 50723 6435493801 459678129
2012 0.0833 4.14e-5 1236686732 51173 6517339078 465524220
2013 0.0833 4.12e-5 1252139596 51621 6598775671 471341119
Min 4.42e-5 1042261758 45937 5492719465 392337105
Mean 4.55e-5 1149486935 48794 6057796146 432699725
Max 4.73e-5 1252139596 51621 6598775671 471341119
Table B.2: Estimate for Parameters Λh and Λh Using Mean Estimates for India in
Table 2.2 and World Bank’s Demographic Estimates in (63)
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Sudan
Year µv µh Nh Λh = µhNh Nv = mv:hNh Λv = µvNv
2000 0.0857 4.73e-5 27729798 1310 146136035 10438288
2001 0.0857 4.70e-5 28434810 1335 149851449 10703675
2002 0.0857 4.67e-5 29186427 1362 153812470 10986605
2003 0.0857 4.63e-5 29973979 1389 157962869 11283062
2004 0.0857 4.60e-5 30778572 1417 162203074 11585934
2005 0.0857 4.57e-5 31585871 1444 166457540 11889824
2006 0.0857 4.54e-5 32397535 1472 170735009 12195358
2007 0.0857 4.52e-5 33218250 1500 175060178 12504298
2008 0.0857 4.49e-5 34040065 1529 179391143 12813653
2009 0.0857 4.47e-5 34853178 1559 183676248 13119732
2010 0.0857 4.46e-5 35652002 1589 187886051 13420432
2011 0.0857 4.44e-5 36430923 1618 191990964 13713640
2012 0.0857 4.43e-5 37195349 1647 196019489 14001392
2013 0.0857 4.42e-5 37964306 1676 200071893 14290849
Min 4.42e-5 27729798 1310 146136035 10438288
Mean 4.55e-5 32817219 1489 172946744 12353339
Max 4.73e-5 37964306 1676 200071893 14290849
Table B.3: Estimate for Parameters Λh and Λh Using Mean Estimates for Sudan in
Table 2.2 and World Bank’s Demographic Estimates in (64)
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